Amedeo Smart

Free Medical Literature Service


 

Amedeo

Tuberculosis

  Free Subscription

Articles published in
PLoS One
    January 2024
  1. VOLKMAN T, Muruganandah V, Graham H, Tosif S, et al
    QuantiFERON Gold-In-Tube for the diagnosis of mycobacterial tuberculosis infection in children under 5 years of age: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0295913.
    >> Share

  2. MUGENYI L, Namuwenge PM, Ouma S, Bakashaba B, et al
    Isoniazid preventive therapy completion between July-September 2019: A comparison across HIV differentiated service delivery models in Uganda.
    PLoS One. 2024;19:e0296239.
    >> Share

  3. PEDRAZ T, Herrera L, Vazquez MC, Ramirez-Rubio O, et al
    The epidemiological situation of tuberculosis in Spain according to surveillance and hospitalization data, 2012-2020.
    PLoS One. 2024;19:e0295918.
    >> Share

  4. HAI BB, Anh TL, Thi Thu PN, Van HN, et al
    Latent and active tuberculosis development in patients with rheumatoid arthritis receiving biologic disease-modifying antirheumatic drugs: A single-center prospective study.
    PLoS One. 2024;19:e0295048.
    >> Share

  5. SPEKKER O, Kiss P A, Kis L, Kiraly K, et al
    White plague among the "forgotten people" from the Barbaricum of the Carpathian Basin-Cases with tuberculosis from the Sarmatian-period (3rd-4th centuries CE) archaeological site of Hodmezovasarhely-Kenyere-er, Bereczki-tanya (Hungary).
    PLoS One. 2024;19:e0294762.
    >> Share

  6. GUPTA A, Juneja S, Babawale V, Rustam Majidovich N, et al
    Global adoption of 6-month drug-resistant TB regimens: Projected uptake by 2026.
    PLoS One. 2024;19:e0296448.
    >> Share

  7. TESFAHUN HM, Al-Salihi L, Abdulkareem Al-Ani N, Mankhi AA, et al
    Management of rifampicin-resistant tuberculosis in conflict-affected areas: The case of Iraq.
    PLoS One. 2024;19:e0296952.
    >> Share

  8. GIVE C, Morris C, Murray J, Jose B, et al
    Sociocultural understanding of Tuberculosis and implications for care-seeking among adults in the province of Zambezia, Mozambique: Qualitative research.
    PLoS One. 2024;19:e0289928.
    >> Share

  9. SANCHEZ-PEREZ HJ, Gordillo-Marroquin C, Vazquez-Marcelin J, Martin-Mateo M, et al
    Sociodemographic factors associated with the success or failure of anti-tuberculosis treatment in the Chiapas Highlands, Mexico, 2019-2022.
    PLoS One. 2024;19:e0296924.
    >> Share

  10. YAMANAKA T, Castro MC, Ferrer JP, Solon JA, et al
    Costs incurred by people with co-morbid tuberculosis and diabetes and their households in the Philippines.
    PLoS One. 2024;19:e0297342.
    >> Share

  11. SSEMASAAZI JA, Bongomin F, Akunzirwe R, Bayowa JR, et al
    Private practitioners' practices for tuberculosis management in a city largely served by the private health sector in Uganda.
    PLoS One. 2024;19:e0296422.
    >> Share

  12. CANTERA JL, Lillis LM, Peck RB, Moreau E, et al
    Correction: Performance of novel antibodies for lipoarabinomannan to develop diagnostic tests for Mycobacterium tuberculosis.
    PLoS One. 2024;19:e0297828.
    >> Share

  13. LAXMESHWAR C, Das M, Mathur T, Israni T, et al
    Correction: Psychiatric comorbidities among patients with complex drug-resistant tuberculosis in Mumbai, India.
    PLoS One. 2024;19:e0298137.
    >> Share

  14. DAWOOD H, Yende-Zuma N, Singh U, Moodley MC, et al
    Incidence and prevalence of hypertension among HIV-TB co-infected participants accessing treatment: A five-year prospective cohort analysis.
    PLoS One. 2024;19:e0297224.
    >> Share

  15. WU Z, Li H, Wu J, Lai X, et al
    The profile of genome-wide DNA methylation, transcriptome, and proteome in streptomycin-resistant Mycobacterium tuberculosis.
    PLoS One. 2024;19:e0297477.
    >> Share

  16. GERBER F, Semphere R, Lukau B, Mahlatsi P, et al
    Same-day versus rapid ART initiation in HIV-positive individuals presenting with symptoms of tuberculosis: Protocol for an open-label randomized non-inferiority trial in Lesotho and Malawi.
    PLoS One. 2024;19:e0288944.
    >> Share

  17. SIMIENEH A, Gashaneh S, Dereje R
    Nutritional status and treatment outcomes of tuberculosis in Mizan Tepi University Teaching Hospital, a five -year retrospective study.
    PLoS One. 2024;19:e0298244.
    >> Share

  18. AJEMA AT, Simachew Y, Meshesha MD, Gari T, et al
    Time to tuberculosis development and its predictors among HIV-positive patients: A retrospective cohort study.
    PLoS One. 2024;19:e0298021.
    >> Share

  19. CHAVAN VV, Dalal A, Nagaraja S, Thekkur P, et al
    Correction: Ambulatory management of pre- and extensively drug resistant tuberculosis patients with imipenem delivered through port-a-cath: A mixed methods study on treatment outcomes and challenges.
    PLoS One. 2024;19:e0299477.
    >> Share

  20. POWELL SM, Jarsberg LG, Zionce ELM, Anderson LN, et al
    Longitudinal analysis of host protein serum signatures of treatment and recovery in pulmonary tuberculosis.
    PLoS One. 2024;19:e0294603.
    >> Share

  21. MESIC A, Khan WH, Lenglet A, Lynen L, et al
    Correction: Translating drug resistant tuberculosis treatment guidelines to reality in war-torn Kandahar, Afghanistan: A retrospective cohort study.
    PLoS One. 2024;19:e0299913.
    >> Share

  22. SERENE LG, Webber K, Champion PA, Schorey JS, et al
    Mycobacterium tuberculosis SecA2-dependent activation of host Rig-I/MAVs signaling is not conserved in Mycobacterium marinum.
    PLoS One. 2024;19:e0281564.
    >> Share

  23. OSMAN M, Meehan SA, von Delft A, Preez KD, et al
    Correction: Early mortality in tuberculosis patients initially lost to follow up following diagnosis in provincial hospitals and primary health care facilities in Western Cape, South Africa.
    PLoS One. 2024;19:e0300768.
    >> Share

  24. CUNHA R, Filho DBM, M Albuquerque MFP, Lacerda HR, et al
    The trajectories of CD4 T lymphocytes over time in patients who have defaulted on treatment for tuberculosis in a cohort of people living with HIV, Recife/PE.
    PLoS One. 2024;19:e0299244.
    >> Share

  25. KAUMBA PC, Siameka D, Kagujje M, Chungu C, et al
    Knowledge, attitudes, and practices towards childhood tuberculosis among healthcare workers at two primary health facilities in Lusaka, Zambia.
    PLoS One. 2024;19:e0287876.
    >> Share

  26. APRIANI L, McAllister S, Sharples K, Aini IN, et al
    Tuberculin skin test and Interferon-gamma release assay agreement, and associated factors with latent tuberculosis infection, in medical and nursing students in Bandung, Indonesia.
    PLoS One. 2024;19:e0299874.
    >> Share

    January 2023
  27. SINHA S, Kumar S, Singh K, Umam F, et al
    Immunochemical characterisation of styrene maleic acid lipid particles prepared from Mycobacterium tuberculosis plasma membrane.
    PLoS One. 2023;18:e0280074.
    >> Share

  28. MOON D, Jeong D, Kang YA, Choi H, et al
    Gender differences in tuberculosis patients with comorbidity: A cross-sectional study using national surveillance data and national health insurance claims data in South Korea.
    PLoS One. 2023;18:e0280678.
    >> Share

  29. ELDUMA AH, Holakouie-Naieni K, Almasi-Hashiani A, Rahimi Foroushani A, et al
    The Targeted Maximum Likelihood estimation to estimate the causal effects of the previous tuberculosis treatment in Multidrug-resistant tuberculosis in Sudan.
    PLoS One. 2023;18:e0279976.
    >> Share

  30. WANG Y, Gao C, Zhao T, Jiao H, et al
    A comparative study of three models to analyze the impact of air pollutants on the number of pulmonary tuberculosis cases in Urumqi, Xinjiang.
    PLoS One. 2023;18:e0277314.
    >> Share

  31. GLYNN JR, Khan P, Mzembe T, Sichali L, et al
    Contribution of remote M.tuberculosis infection to tuberculosis disease: A 30-year population study.
    PLoS One. 2023;18:e0278136.
    >> Share

  32. NAGARAJAN K, Muniyandi M, Sellappan S, Karunanidhi S, et al
    A study on tuberculosis disease disclosure patterns and its associated factors: Findings from a prospective observational study in Chennai.
    PLoS One. 2023;18:e0280812.
    >> Share

  33. LESTARI T, Fuady A, Yani FF, Putra IWGAE, et al
    The development of the national tuberculosis research priority in Indonesia: A comprehensive mixed-method approach.
    PLoS One. 2023;18:e0281591.
    >> Share

  34. ERESO BM, Sagbakken M, Gradmann C, Yimer SA, et al
    Total delay and associated factors among tuberculosis patients in Jimma Zone, Southwest Ethiopia.
    PLoS One. 2023;18:e0281546.
    >> Share

  35. ZHANG Y, Ye J, Hou S, Lu X, et al
    Spatial-temporal analysis of pulmonary tuberculosis in Hubei Province, China, 2011-2021.
    PLoS One. 2023;18:e0281479.
    >> Share

  36. CORONEL TEIXEIRA R, Gomez L, Gonzalez E, Jimenez de Romero N, et al
    The accuracy of an electronic nose to diagnose tuberculosis in patients referred to an expert centre.
    PLoS One. 2023;18:e0276045.
    >> Share

  37. SANT ANNA FM, Araujo-Pereira M, Schmaltz CAS, Arriaga MB, et al
    Impact of adverse drug reactions on the outcomes of tuberculosis treatment.
    PLoS One. 2023;18:e0269765.
    >> Share

  38. WAKJIRA MK, Sandy PT, Mavhandu-Mudzusi AH
    Patients' perceived quality of care and their satisfaction with care given for MDR-TB at referral hospitals in Ethiopia.
    PLoS One. 2023;18:e0270439.
    >> Share

  39. SEID G, Alemu A, Dagne B, Gamtesa DF, et al
    Microbiological diagnosis and mortality of tuberculosis meningitis: Systematic review and meta-analysis.
    PLoS One. 2023;18:e0279203.
    >> Share

  40. BARAKAT A, Birkeland E, Jorstad MD, El Hajj M, et al
    Proteomic analysis of peripheral blood mononuclear cells isolated from patients with pulmonary tuberculosis: A pilot study from Zanzibar, Tanzania.
    PLoS One. 2023;18:e0281757.
    >> Share

  41. PIETERSEN E, Anderson K, Cox H, Dheda K, et al
    Variation in missed doses and reasons for discontinuation of anti-tuberculosis drugs during hospital treatment for drug-resistant tuberculosis in South Africa.
    PLoS One. 2023;18:e0281097.
    >> Share

  42. AZIZ ZA, Noordin NM, Wan Mohd WM, Kasim MA, et al
    First evaluation of the performance of portable IGRA, QIAreach(R) QuantiFERON(R)-TB in intermediate TB incidence setting.
    PLoS One. 2023;18:e0279882.
    >> Share

  43. MUSAAZI J, Sekaggya-Wiltshire C, Okoboi S, Zawedde-Muyanja S, et al
    Increased uptake of tuberculosis preventive therapy (TPT) among people living with HIV following the 100-days accelerated campaign: A retrospective review of routinely collected data at six urban public health facilities in Uganda.
    PLoS One. 2023;18:e0268935.
    >> Share

  44. COLA JP, Prado TND, Campos BA, Borges BJP, et al
    Protocol for pragmatic randomized clinical trial to evaluate the completion of treatment of latent Mycobacterium tuberculosis infection with Isoniazid in the 300 mg formulation.
    PLoS One. 2023;18:e0281638.
    >> Share

  45. MONDAL R, Dusthackeer V N A, Kannan P, Singh AK, et al
    In-vivo studies on Transitmycin, a potent Mycobacterium tuberculosis inhibitor.
    PLoS One. 2023;18:e0282454.
    >> Share

  46. KETER AK, Lynen L, Van Heerden A, Wong E, et al
    Evaluation of tuberculosis diagnostic test accuracy using Bayesian latent class analysis in the presence of conditional dependence between the diagnostic tests used in a community-based tuberculosis screening study.
    PLoS One. 2023;18:e0282417.
    >> Share

  47. MATJI R, Maama L, Roscigno G, Lerotholi M, et al
    Policy and programmatic directions for the Lesotho tuberculosis programme: Findings of the national tuberculosis prevalence survey, 2019.
    PLoS One. 2023;18:e0273245.
    >> Share

  48. KHOR LA, A Wahid UNI, Ling LL, Liansim SMS, et al
    Prevalence and associated factors of delayed sputum smear conversion in patients treated for smear positive pulmonary tuberculosis: A retrospective follow up study in Sabah, Malaysia.
    PLoS One. 2023;18:e0282733.
    >> Share

  49. KIM S, Hesseling AC, Wu X, Hughes MD, et al
    Factors associated with prevalent Mycobacterium tuberculosis infection and disease among adolescents and adults exposed to rifampin-resistant tuberculosis in the household.
    PLoS One. 2023;18:e0283290.
    >> Share

  50. CASTLE AC, Hoeppner SS, Magodoro IM, Singh U, et al
    Association between prior tuberculosis disease and dysglycemia within an HIV-endemic, rural South African population.
    PLoS One. 2023;18:e0282371.
    >> Share

  51. MBUYA AW, Mboya IB, Semvua HH, Mamuya SH, et al
    Prevalence and factors associated with tuberculosis among the mining communities in Mererani, Tanzania.
    PLoS One. 2023;18:e0280396.
    >> Share

  52. BRAZIER E, Maruri F, Wester CW, Musick B, et al
    Design and implementation of a global site assessment survey among HIV clinics participating in the International epidemiology Databases to Evaluate AIDS (IeDEA) research consortium.
    PLoS One. 2023;18:e0268167.
    >> Share

  53. MATULYTE E, Davidaviciene E, Kancauskiene Z, Diktanas S, et al
    The socio-demographic, clinical characteristics and outcomes of tuberculosis among HIV infected adults in Lithuania: A thirteen-year analysis.
    PLoS One. 2023;18:e0282046.
    >> Share

  54. GEMECHU LL, Debusho LK
    Bayesian spatial modelling of tuberculosis-HIV co-infection in Ethiopia.
    PLoS One. 2023;18:e0283334.
    >> Share

  55. MOHAMMAD RAHIMI H, Javanmard E, Taghipour A, Haghighi A, et al
    Multigene typing of Giardia Duodenalis isolated from tuberculosis and non-tuberculosis subjects.
    PLoS One. 2023;18:e0283515.
    >> Share

  56. AMARE D, Getahun FA, Mengesha EW, Dessie G, et al
    Effectiveness of healthcare workers and volunteers training on improving tuberculosis case detection: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0271825.
    >> Share

  57. WILLGERT K, da Silva S, Li R, Dandapat P, et al
    Is bovine density and ownership associated with human tuberculosis in India?
    PLoS One. 2023;18:e0283357.
    >> Share

  58. MOYO N, Tay EL, Trauer JM, Burke L, et al
    Tuberculosis notifications in regional Victoria, Australia: Implications for public health care in a low incidence setting.
    PLoS One. 2023;18:e0282884.
    >> Share

  59. MOYO S, Ismail F, Mkhondo N, van der Walt M, et al
    Healthcare seeking patterns for TB symptoms: Findings from the first national TB prevalence survey of South Africa, 2017-2019.
    PLoS One. 2023;18:e0282125.
    >> Share

  60. SINHA S, Thukral H, Shareef I, Desai D, et al
    Prevention of relapse in drug sensitive pulmonary tuberculosis patients with and without vitamin D3 supplementation: A double blinded randomized control clinical trial.
    PLoS One. 2023;18:e0272682.
    >> Share

  61. MAYITO J, Martineau AR, Tiwari D, Nakiyingi L, et al
    Determinants of QuantiFERON Plus-diagnosed tuberculosis infection in adult Ugandan TB contacts: A cross-sectional study.
    PLoS One. 2023;18:e0281559.
    >> Share

  62. SUDCHAROEN A, Ruchikajorndech G, Srisajjakul S, Pongpaibul A, et al
    Clinical characteristics and diagnosis of intestinal tuberculosis in clinical practice at Thailand's largest national tertiary referral center: An 11-year retrospective review.
    PLoS One. 2023;18:e0282392.
    >> Share

  63. MARTINEZ-OLIVARES CE, Hernandez-Pando R, Mixcoha E
    In silico EsxG EsxH rational epitope selection: Candidate epitopes for vaccine design against pulmonary tuberculosis.
    PLoS One. 2023;18:e0284264.
    >> Share

  64. PARK S, Sung C, Choi H, Lee YW, et al
    Comparison of active tuberculosis case finding strategies for immigrants in South Korea: Epidemiology and cost-effectiveness analysis.
    PLoS One. 2023;18:e0283414.
    >> Share

  65. SIMMONS JD, Segnitz RM, Dill-McFarland KA, Stein CM, et al
    Differentially expressed transcript isoforms associate with resistance to tuberculin skin test and interferon gamma release assay conversion.
    PLoS One. 2023;18:e0284498.
    >> Share

  66. NGO DM, Doan NB, Tran SN, Hoang LB, et al
    Practice regarding tuberculosis care among physicians at private facilities: A cross-sectional study from Vietnam.
    PLoS One. 2023;18:e0284603.
    >> Share

  67. MOGA S, Bobosha K, Fikadu D, Zerihun B, et al
    Diagnostic performance of the GenoType MTBDRplus VER 2.0 line probe assay for the detection of isoniazid resistant Mycobacterium tuberculosis in Ethiopia.
    PLoS One. 2023;18:e0284737.
    >> Share

  68. SESSOLO A, Musisi E, Kaswabuli S, Zawedde J, et al
    Diagnostic accuracy of Xpert MTB/RIF Ultra and culture assays to detect Mycobacterium Tuberculosis using OMNIgene-sputum processed stool among adult TB presumptive patients in Uganda.
    PLoS One. 2023;18:e0284041.
    >> Share

  69. ANDOM AT, Gilbert HN, Ndayizigiye M, Mukherjee JS, et al
    Understanding barriers to tuberculosis diagnosis and treatment completion in a low-resource setting: A mixed-methods study in the Kingdom of Lesotho.
    PLoS One. 2023;18:e0285774.
    >> Share

  70. GOROH MMD, van den Boogaard CHA, Lukman KA, Lowbridge C, et al
    Factors affecting implementation of tuberculosis contact investigation and tuberculosis preventive therapy among children in Sabah, East Malaysia: A qualitative study.
    PLoS One. 2023;18:e0285534.
    >> Share

  71. SILVA WCD, Camargo RNC Junior, Silva EBRD, Silva JARD, et al
    Perspectives of economic losses due to condemnation of cattle and buffalo carcasses in the northern region of Brazil.
    PLoS One. 2023;18:e0285224.
    >> Share

  72. BAENA A, Cabarcas F, Ocampo JC, Barrera LF, et al
    Large genomic deletions delineate Mycobacterium tuberculosis L4 sublineages in South American countries.
    PLoS One. 2023;18:e0285417.
    >> Share

  73. MAIN S, Triasih R, Greig J, Hidayat A, et al
    The prevalence and risk factors for tuberculosis among healthcare workers in Yogyakarta, Indonesia.
    PLoS One. 2023;18:e0279215.
    >> Share

  74. AKALU TY, Clements ACA, Baraki AG, Alene KA, et al
    Protocol for a systematic review of long-term physical sequelae and financial burden of multidrug-resistant and extensively drug-resistant tuberculosis.
    PLoS One. 2023;18:e0285404.
    >> Share

  75. KAMBLE S, Shidhaye P, Mukherjee A, Tak M, et al
    A protocol for feasibility of plasma based GeneXpert platform and Dried Blood Spot (DBS) based Abbott platform for HIV-1 viral load testing among the people living with HIV attending ART centers in India.
    PLoS One. 2023;18:e0285942.
    >> Share

  76. HASAN MZ, Ahmed S, Islam Z, Dorin F, et al
    Costs of services and funding gap of the Bangladesh National Tuberculosis Control Programme 2016-2022: An ingredient based approach.
    PLoS One. 2023;18:e0286560.
    >> Share

  77. D FREIRE I, L Fielding K, A J Moore D
    Does diabetes mellitus comorbidity increase the risk of drug-induced liver injury during tuberculosis treatment?
    PLoS One. 2023;18:e0286306.
    >> Share

  78. SHARANI ZZ, Ismail N, Yasin SM, Isa MR, et al
    T-BACCO SCORE: A predictive scoring tool for tuberculosis (TB) loss to follow-up among TB smokers.
    PLoS One. 2023;18:e0287374.
    >> Share

  79. BAATJIES L, van Rensberg IC, Snyders C, Gutschmidt A, et al
    Investigating Mycobacterium tuberculosis sufR (rv1460) in vitro and ex vivo expression and immunogenicity.
    PLoS One. 2023;18:e0286965.
    >> Share

  80. ALEMU A, Bitew ZW, Diriba G, Seid G, et al
    Poor treatment outcome and associated risk factors among patients with isoniazid mono-resistant tuberculosis: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0286194.
    >> Share

  81. KAGUJJE M, Nyangu S, Maimbolwa MM, Shuma B, et al
    Strategies to increase childhood tuberculosis case detection at the primary health care level: Lessons from an active case finding study in Zambia.
    PLoS One. 2023;18:e0288643.
    >> Share

  82. FEKADU G, Wang Y, You JHS
    Standard diagnostics with and without urine-based lipoarabinomannan testing for tuberculosis disease in HIV-infected patients in a high-burden setting-A cost-effectiveness analysis.
    PLoS One. 2023;18:e0288605.
    >> Share

  83. PONGMA C, Songthammanuphap S, Puthong S, Buakeaw A, et al
    Using whole blood cultures in interferon gamma release assays to detect Mycobacterium tuberculosis complex infection in Asian elephants (Elephas maximus).
    PLoS One. 2023;18:e0288161.
    >> Share

  84. GEORGE S, Syamala TS, Paranjpe A, Saalim M, et al
    Intersections of informal work status, gender and tuberculosis diagnosis: Insights from a qualitative study from an Indian setting.
    PLoS One. 2023;18:e0289137.
    >> Share

  85. XIE M, Tsai CY, McAdams ZL, Oo M, et al
    Wild mouse gut microbiota limits initial tuberculosis infection in BALB/c mice.
    PLoS One. 2023;18:e0288290.
    >> Share

  86. MEKONNEN E, Arega M, Belay DM, Birhanu D, et al
    Time to death and its predictors among under-five children on antiretroviral treatment in public hospitals of Addis Ababa, Addis Ababa, Ethiopia, a retrospective follow up study.
    PLoS One. 2023;18:e0288475.
    >> Share

  87. KURTZ SL, Ryden P, Elkins KL
    Transcriptional signatures measured in whole blood correlate with protection against tuberculosis in inbred and outbred mice.
    PLoS One. 2023;18:e0289358.
    >> Share

  88. KABORE OD, Millogo A, Sanogo B, Birba E, et al
    Analytical performances of the Xpert MTB/RIF assay using stool specimens to improve the diagnosis of pulmonary tuberculosis in Burkina Faso, a tuberculosis endemic country.
    PLoS One. 2023;18:e0288671.
    >> Share

  89. MOLLALIGN H, Getahun M, Diriba G, Alemu A, et al
    Genetic diversity and drug sensitivity profile of Mycobacterium tuberculosis among children in Ethiopia.
    PLoS One. 2023;18:e0284363.
    >> Share

  90. LOLONG DB, Aryastami NK, Kusrini I, Tobing KL, et al
    Nonadherence to anti-tuberculosis treatment, reasons and associated factors among pulmonary tuberculosis patients in the communities in Indonesia.
    PLoS One. 2023;18:e0287628.
    >> Share

  91. KATAMBA A, Ssengooba W, Sserubiri J, Semugenze D, et al
    Evaluation of Xpert MTB/XDR test for susceptibility testing of Mycobacterium tuberculosis to first and second-line drugs in Uganda.
    PLoS One. 2023;18:e0284545.
    >> Share

  92. BERROCAL-ALMANZA LC, Lima M, Piotrowski H, Botticello J, et al
    Vulnerability and tuberculosis treatment outcomes in urban settings in England: A mixed-methods study.
    PLoS One. 2023;18:e0281918.
    >> Share

  93. GARG T, Nonyane BAS, Mohlamonyane M, Lebina L, et al
    Investigating linkage to care between hospitals and primary care clinics for people with TB in rural South Africa.
    PLoS One. 2023;18:e0289830.
    >> Share

  94. MASSUD A, Khan AH, Syed Sulaiman SA, Ahmad N, et al
    Unsuccessful treatment outcome and associated risk factors. A prospective study of DR-TB patients from a high burden country, Pakistan.
    PLoS One. 2023;18:e0287966.
    >> Share

  95. SEJIE GA, Mahomed OH
    Potential facilitators and inhibitors to the implementation and sustainability of the community-based tuberculosis care interventions. A case study from Moshupa, Botswana.
    PLoS One. 2023;18:e0290010.
    >> Share

  96. MALECHE-OBIMBO E, Attia E, Were F, Jaoko W, et al
    Prevalence, clinical presentation and factors associated with chronic lung disease among children and adolescents living with HIV in Kenya.
    PLoS One. 2023;18:e0289756.
    >> Share

  97. MALHOTRA A, Thompson R, De Vos M, David A, et al
    Determining cost and placement decisions for moderate complexity NAATs for tuberculosis drug susceptibility testing.
    PLoS One. 2023;18:e0290496.
    >> Share

  98. MEESAWAT S, Aiempichitkijkarn N, Warit S, Kaewparuehaschai M, et al
    Non-invasive specimen collections for Mycobacterium tuberculosis detection in free-ranging long-tailed macaques (Macaca fascicularis).
    PLoS One. 2023;18:e0289961.
    >> Share

  99. AUNG PL, Win KM, Win Maung HM, Show KL, et al
    Determinants of correct knowledge on tuberculosis transmission and self-reported tuberculosis prevalence among general population aged 15-49 years in Myanmar.
    PLoS One. 2023;18:e0290470.
    >> Share

  100. LERTUDOMPHONWANIT T, Somboonprasert C, Lilakhunakon K, Jaovisidha S, et al
    A clinical prediction model to differentiate tuberculous spondylodiscitis from pyogenic spontaneous spondylodiscitis.
    PLoS One. 2023;18:e0290361.
    >> Share

  101. MOTTA CP, Olimpio da Silva DL, da Costa LR, Galhardo GF, et al
    Performance during the Glittre-ADL test between patients with and without post-tuberculosis bronchiectasis: A cross-sectional study.
    PLoS One. 2023;18:e0290850.
    >> Share

  102. MA Z, Fan H
    Influential factors of tuberculosis in mainland China based on MGWR model.
    PLoS One. 2023;18:e0290978.
    >> Share

  103. PEREZ-RECIO S, Grijota-Camino MD, Anibarro L, Rabunal-Rey R, et al
    Reversions of QuantiFERON-TB Gold Plus in tuberculosis contact investigation: A prospective multicentre cohort study.
    PLoS One. 2023;18:e0285917.
    >> Share

  104. RAMSAY LC, Marina Richardson, Miranda RN, Hassan M, et al
    Inclusion of non-medical interventions in model-based economic evaluations for tuberculosis: A scoping review.
    PLoS One. 2023;18:e0290710.
    >> Share

  105. GETAHUN DA, Layland LE, Hoerauf A, Wondale B, et al
    Impact of the use of GeneXpert on TB diagnosis and anti-TB treatment outcome at health facilities in Addis Ababa, Ethiopia in the post-millennium development years.
    PLoS One. 2023;18:e0289917.
    >> Share

  106. TOK PSK, Wong LP, Liew SM, Razali A, et al
    A qualitative exploration of tuberculosis patients who were lost to follow-up in Malaysia.
    PLoS One. 2023;18:e0289222.
    >> Share

  107. TORNU E, Jordan P, McCaul M
    Best practice guidelines for professional nurses to provide self-management support to adults with tuberculosis-human immunodeficiency virus coinfection: A scoping review.
    PLoS One. 2023;18:e0291529.
    >> Share

  108. SIBHAT MM, Mulugeta TN, Aklilu DW
    Incidence of switching to second-line antiretroviral therapy and its predictors among children on antiretroviral therapy at general hospitals, Northern Ethiopia: A survival analysis.
    PLoS One. 2023;18:e0288132.
    >> Share

  109. KARANJA S, Aduda J, Thuo R, Wamunyokoli F, et al
    Utilization of digital tools to enhance COVID-19 and tuberculosis testing and linkage to care: A cross-sectional evaluation study among Bodaboda motorbike riders in the Nairobi Metropolis, Kenya.
    PLoS One. 2023;18:e0290575.
    >> Share

  110. TILAHUN M, Wegayehu T, Wondale B, Gebresilase TT, et al
    Phenotypic and genotypic drug susceptibility patterns of Mycobacterium tuberculosis isolates from pulmonary tuberculosis patients in Central and Southern Ethiopia.
    PLoS One. 2023;18:e0285063.
    >> Share

  111. ROMANOWSKI K, Karim ME, Gilbert M, Cook VJ, et al
    Distinct healthcare utilization profiles of high healthcare use tuberculosis survivors: A latent class analysis.
    PLoS One. 2023;18:e0291997.
    >> Share

  112. TEKESE D, Dawit D, Hawulte B, Mohammed H, et al
    Incidence and predictors of tuberculosis among children receiving antiretroviral therapy in the Wolaita Zone: A retrospective cohort study.
    PLoS One. 2023;18:e0291502.
    >> Share

  113. EREM G, Otike C, Okuja M, Ameda F, et al
    Diagnostic accuracy of chest ultrasound scan in the diagnosis of childhood tuberculosis.
    PLoS One. 2023;18:e0287621.
    >> Share

  114. OSEI E, Amu H, Kye-Duodu G, Kwabla MP, et al
    Impact of COVID-19 pandemic on Tuberculosis and HIV services in Ghana: An interrupted time series analysis.
    PLoS One. 2023;18:e0291808.
    >> Share

  115. ISLAM MS, Gurley ES, Banu S, Hossain K, et al
    Prevalence and incidence of tuberculosis infection among healthcare workers in chest diseases hospitals, Bangladesh: Putting infection control into context.
    PLoS One. 2023;18:e0291484.
    >> Share

  116. WINTERS N, Schnitzer ME, Campbell JR, Ripley S, et al
    Identifying patients with multidrug-resistant tuberculosis who may benefit from shorter durations of treatment.
    PLoS One. 2023;18:e0292106.
    >> Share

  117. ZERIHUN M, Mekonnen H, Gebretensaye TG
    Treatment outcome and associated factors among adult patients with pulmonary tuberculosis in selected health centers in Addis Ababa Ethiopia.
    PLoS One. 2023;18:e0292218.
    >> Share

  118. CHAWLA K, Burugina Nagaraja S, Siddalingaiah N, Sanju C, et al
    Tuberculosis screening for pediatric household contacts in India: Time to adapt newer strategies under the National TB Elimination Programme!
    PLoS One. 2023;18:e0292387.
    >> Share

  119. MOENS C, Filee P, Boes A, Alie C, et al
    Identification of New Mycobacterium bovis antigens and development of a multiplexed serological bead-immunoassay for the diagnosis of bovine tuberculosis in cattle.
    PLoS One. 2023;18:e0292590.
    >> Share

  120. VERBOVEN L, Phelan J, Heupink TH, Van Rie A, et al
    Correction: TBProfiler for automated calling of the association with drug resistance of variants in Mycobacterium tuberculosis.
    PLoS One. 2023;18:e0293254.
    >> Share

  121. MEJIA-PONCE PM, Ramos-Gonzalez EJ, Ramos-Garcia AA, Lara-Ramirez EE, et al
    Genomic epidemiology analysis of drug-resistant Mycobacterium tuberculosis distributed in Mexico.
    PLoS One. 2023;18:e0292965.
    >> Share

  122. MUSHTAQ F, Raza SM, Ahmad A, Aslam H, et al
    Antimicrobial drug resistant features of Mycobacterium tuberculosis associated with treatment failure.
    PLoS One. 2023;18:e0293194.
    >> Share

  123. HAVUMAKI J, Warren JL, Zelner J, Menzies NA, et al
    Spatially-targeted tuberculosis screening has limited impact beyond household contact tracing in Lima, Peru: A model-based analysis.
    PLoS One. 2023;18:e0293519.
    >> Share

  124. MANDO TC, Sandy C, Chadambuka A, Gombe NT, et al
    Tuberculosis cohort analysis in Zimbabwe: The need to strengthen patient follow-up throughout the tuberculosis care cascade.
    PLoS One. 2023;18:e0293867.
    >> Share

  125. VERMA-KUMAR S, Abraham D, Dendukuri N, Cheeran JV, et al
    Correction: Serodiagnosis of Tuberculosis in Asian Elephants (Elephas maximus) in Southern India: A Latent Class Analysis.
    PLoS One. 2023;18:e0294550.
    >> Share

  126. GRAY AT, Macpherson L, Carlin F, Sossen B, et al
    Treatment for radiographically active, sputum culture-negative pulmonary tuberculosis: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0293535.
    >> Share

  127. SHIN HJ, Yoon JY, Na YO, Lee JK, et al
    Major adverse cardiovascular events and hyperuricemia during tuberculosis treatment.
    PLoS One. 2023;18:e0294490.
    >> Share

  128. YANG Y, Liu L, Yang X, Li L, et al
    Changing trend analysis on early detection of rifampicin resistant tuberculosis patients in southwestern area of China, 2016-2020.
    PLoS One. 2023;18:e0280578.
    >> Share

  129. MAYITO J, Meya DB, Miriam A, Dhikusooka F, et al
    Monocyte to Lymphocyte ratio is highly specific in diagnosing latent tuberculosis and declines significantly following tuberculosis preventive therapy: A cross-sectional and nested prospective observational study.
    PLoS One. 2023;18:e0291834.
    >> Share

  130. TRIVEDI P, Chaturvedi V
    Interactive effect of oral anti-hyperglycaemic or anti-hypertensive drugs on the inhibitory and bactericidal activity of first line anti-TB drugs against M. tuberculosis.
    PLoS One. 2023;18:e0292397.
    >> Share

  131. AFFUL P, Vechey GA, Leta PK, Gbafu FB, et al
    Predictors of multidrug-resistant tuberculosis in a teaching hospital in Ghana: A case-control study.
    PLoS One. 2023;18:e0294928.
    >> Share

  132. SHEN Y, Fang L, Ye B, Yu G, et al
    Meta-analysis of diagnostic accuracy of nucleic acid amplification tests for abdominal tuberculosis.
    PLoS One. 2023;18:e0289336.
    >> Share

  133. SPRUIJT I, Alam Y, Nguyen H, Myrzaliev B, et al
    Digital health solutions and integrated COVID-19 and TB services to help recover TB care and prevention services in the COVID-19 pandemic: A descriptive study in four high TB burden countries.
    PLoS One. 2023;18:e0293964.
    >> Share

  134. MOREY-LEON G, Mejia-Ponce PM, Granda Pardo JC, Munoz-Mawyin K, et al
    A precision overview of genomic resistance screening in Ecuadorian isolates of Mycobacterium tuberculosis using web-based bioinformatics tools.
    PLoS One. 2023;18:e0294670.
    >> Share

  135. BONGOMIN F, Olum R, Kibone W, Namusobya M, et al
    Prevalence of chronic pulmonary aspergillosis along the continuum of pulmonary tuberculosis care: A protocol for a living systematic review and meta-analysis.
    PLoS One. 2023;18:e0294634.
    >> Share

  136. KWAK SH, Jeong D, Mok J, Jeon D, et al
    Association between diabetes mellitus and cause of death in patients with tuberculosis: A Korean nationwide cohort study.
    PLoS One. 2023;18:e0295556.
    >> Share

  137. NOIA MACIEL EL, Negri LDSA, Guidoni LM, Fregona GC, et al
    The economic burden of households affected by tuberculosis in Brazil: First national survey results, 2019-2021.
    PLoS One. 2023;18:e0287961.
    >> Share

  138. TIRUNEH MG, Fenta ET, Anagaw TF, Bogale EK, et al
    Tuberculosis infection control practice and associated factors among health care workers in Ethiopia: Systematic review and meta-analysis.
    PLoS One. 2023;18:e0295555.
    >> Share

  139. SCIAUDONE M, Carpena R, Calderon M, Sheen P, et al
    Rapid detection of Mycobacterium tuberculosis using recombinase polymerase amplification: A pilot study.
    PLoS One. 2023;18:e0295610.
    >> Share

  140. ODONGO D, Omech B, Acanga A
    Cost-effectiveness analysis of adding tuberculosis household contact investigation on passive case-finding strategy in Southwestern Uganda.
    PLoS One. 2023;18:e0288761.
    >> Share

  141. GIRIDHARAN P, Selvaraju S, Rao R, Rade K, et al
    Recurrence of pulmonary tuberculosis in India: Findings from the 2019-2021 nationwide community-based TB prevalence survey.
    PLoS One. 2023;18:e0294254.
    >> Share

  142. JAMIL B, Nair D, Thekkur P, Laeeq N, et al
    Feasibility, enablers and challenges of using timeliness metrics for household contact tracing and TB preventive therapy in Pakistan.
    PLoS One. 2023;18:e0295580.
    >> Share

  143. MACGREGOR-FAIRLIE M, De Gomes P, Weston D, Rickard JJS, et al
    Hybrid use of Raman spectroscopy and artificial neural networks to discriminate Mycobacterium bovis BCG and other Mycobacteriales.
    PLoS One. 2023;18:e0293093.
    >> Share

  144. ATRE S, Jagtap J, Faqih M, Dumbare Y, et al
    Addressing patients' unmet needs related to multidrug-resistant tuberculosis (MDR-TB) care: A qualitative research study from Pune city, India.
    PLoS One. 2023;18:e0295508.
    >> Share

  145. GILS T, Kamele M, Madonsela T, Bosman S, et al
    Implementation of the advanced HIV disease care package with point-of-care CD4 testing during tuberculosis case finding: A mixed-methods evaluation.
    PLoS One. 2023;18:e0296197.
    >> Share

    January 2022
  146. LUNGU P, Njelesani E, Sukwa T, Ngalamika O, et al
    Immune correlates of Mycobacterium Tuberculosis patients in Zambia stratified by HIV serostatus and level of immunity-a cross-sectional analytical laboratory based study.
    PLoS One. 2022;17:e0262454.
    >> Share

  147. BURKE RM, Nyirenda S, Twabi HH, Nliwasa M, et al
    Design and protocol for a cluster randomised trial of enhanced diagnostics for tuberculosis screening among people living with HIV in hospital in Malawi (CASTLE study).
    PLoS One. 2022;17:e0261877.
    >> Share

  148. GUO S, Chongsuvivatwong V, Guo M, Lei S, et al
    Yield, NNS and prevalence of screening for DM and hypertension among pulmonary tuberculosis index cases and contacts through single time screening: A contact tracing-based study.
    PLoS One. 2022;17:e0263308.
    >> Share

  149. ADHIKARI N, Bhattarai RB, Basnet R, Joshi LR, et al
    Prevalence and associated risk factors for tuberculosis among people living with HIV in Nepal.
    PLoS One. 2022;17:e0262720.
    >> Share

  150. MATEYO K, Kerkhoff AD, Dunn I, Nteeni MS, et al
    Clinical and radiographic characteristics of presumptive tuberculosis patients previously treated for tuberculosis in Zambia.
    PLoS One. 2022;17:e0263116.
    >> Share

  151. ADMASSU W, Ayelign B, Abebe G, Tadesse M, et al
    Detection of Mycobacterium tuberculosis and rifampicin resistance by Xpert(R) MTB/RIF assay among presumptive tuberculosis cases at Jimma University Medical Center, Southwest Ethiopia.
    PLoS One. 2022;17:e0262929.
    >> Share

  152. DE PAIVA JPS, Magalhaes MAFM, Leal TC, da Silva LF, et al
    Time trend, social vulnerability, and identification of risk areas for tuberculosis in Brazil: An ecological study.
    PLoS One. 2022;17:e0247894.
    >> Share

  153. PHUOC LONG N, Heo DY, Park S, Thi Hai Yen N, et al
    Molecular perturbations in pulmonary tuberculosis patients identified by pathway-level analysis of plasma metabolic features.
    PLoS One. 2022;17:e0262545.
    >> Share

  154. WALLIS RS, Ginindza S, Beattie T, Arjun N, et al
    Lung and blood early biomarkers for host-directed tuberculosis therapies: Secondary outcome measures from a randomized controlled trial.
    PLoS One. 2022;17:e0252097.
    >> Share

  155. SIMIENEH A, Tadesse M, Kebede W, Gashaw M, et al
    Combination of Xpert(R) MTB/RIF and DetermineTM TB-LAM Ag improves the diagnosis of extrapulmonary tuberculosis at Jimma University Medical Center, Oromia, Ethiopia.
    PLoS One. 2022;17:e0263172.
    >> Share

  156. LAXMESHWAR C, Das M, Mathur T, Israni T, et al
    Psychiatric comorbidities among patients with complex drug-resistant tuberculosis in Mumbai, India.
    PLoS One. 2022;17:e0263759.
    >> Share

  157. BROOKS MB, Dubois MM, Malik AA, Ahmed JF, et al
    Age-specific effectiveness of a tuberculosis screening intervention in children.
    PLoS One. 2022;17:e0264216.
    >> Share

  158. GHIMIRE A, Mahendradhata Y, Paudel S, Lama Yonzon C, et al
    Implementation fidelity of tuberculosis preventive therapy for under five children exposed to sputum smear positive pulmonary tuberculosis in Kaski district, Nepal: An implementation research.
    PLoS One. 2022;17:e0263967.
    >> Share

  159. CARNEY T, Rooney JA, Niemand N, Myers B, et al
    Transmission Of Tuberculosis Among illicit drug use Linkages (TOTAL): A cross-sectional observational study protocol using respondent driven sampling.
    PLoS One. 2022;17:e0262440.
    >> Share

  160. ADJOBIMEY M, Ade S, Wachinou P, Esse M, et al
    Prevalence, acceptability, and cost of routine screening for pulmonary tuberculosis among pregnant women in Cotonou, Benin.
    PLoS One. 2022;17:e0264206.
    >> Share

  161. SOEROTO AY, Nurhayati RD, Purwiga A, Lestari BW, et al
    Factors associated with treatment outcome of MDR/RR-TB patients treated with shorter injectable based regimen in West Java Indonesia.
    PLoS One. 2022;17:e0263304.
    >> Share

  162. LACOURSE SM, Seko E, Wood R, Bundi W, et al
    Diagnostic performance of oral swabs for non-sputum based TB diagnosis in a TB/HIV endemic setting.
    PLoS One. 2022;17:e0262123.
    >> Share

  163. WATANABE Y, Nakagawa T, Fukai K, Honda T, et al
    Descriptive study of chest x-ray examination in mandatory annual health examinations at the workplace in Japan.
    PLoS One. 2022;17:e0262404.
    >> Share

  164. BELAKEHAL F, Barth SA, Menge C, Mossadak HT, et al
    Evaluation of the discriminatory power of spoligotyping and 19-locus mycobacterial interspersed repetitive unit-variable number of tandem repeat analysis (MIRU-VNTR) of Mycobacterium bovis strains isolated from cattle in Algeria.
    PLoS One. 2022;17:e0262390.
    >> Share

  165. ACKHTER MM, Shahid ASMSB, Ahmed T, Palit P, et al
    Characteristics of severely malnourished under-five children immunized with Bacillus Calmette-Guerin following Expanded Programme on Immunization schedule and their outcomes during hospitalization at an urban diarrheal treatment centre, Bangladesh.
    PLoS One. 2022;17:e0262391.
    >> Share

  166. MAGHRADZE N, Jugheli L, Borrell S, Tukvadze N, et al
    Developing customized stepwise MIRU-VNTR typing for tuberculosis surveillance in Georgia.
    PLoS One. 2022;17:e0264472.
    >> Share

  167. WAKJIRA MK, Sandy PT, Mavhandu-Mudzusi AH
    Treatment outcomes of patients with MDR-TB and its determinants at referral hospitals in Ethiopia.
    PLoS One. 2022;17:e0262318.
    >> Share

  168. ISLAM MS, Tarannum S, Banu S, Chowdhury KIA, et al
    Preparedness of tertiary care hospitals to implement the national TB infection prevention and control guidelines in Bangladesh: A qualitative exploration.
    PLoS One. 2022;17:e0263115.
    >> Share

  169. DLATU N, Longo-Mbenza B, Apalata T
    Predictors of tuberculosis incidence and the effects of multiple deprivation indices on tuberculosis management in OR Tambo district over a 5-year period.
    PLoS One. 2022;17:e0264811.
    >> Share

  170. NADJIB M, Dewi RK, Setiawan E, Miko TY, et al
    Cost and affordability of scaling up tuberculosis diagnosis using Xpert MTB/RIF testing in West Java, Indonesia.
    PLoS One. 2022;17:e0264912.
    >> Share

  171. SOLTOBEKOVA N, Kozukeev T, Yiehdego G, Labib F, et al
    Time to start of tuberculosis treatment in penitentiary system of Kyrgyz Republic: A retrospective cohort study.
    PLoS One. 2022;17:e0264252.
    >> Share

  172. FLORENTINO JL, Arao RML, Garfin AMC, Gaviola DMG, et al
    Expansion of social protection is necessary towards zero catastrophic costs due to TB: The first national TB patient cost survey in the Philippines.
    PLoS One. 2022;17:e0264689.
    >> Share

  173. ZHAO D, Zhang H, Cao Q, Wang Z, et al
    The research of ARIMA, GM(1,1), and LSTM models for prediction of TB cases in China.
    PLoS One. 2022;17:e0262734.
    >> Share

  174. CHIHOTA VN, Ntshiqa T, Maenetje P, Mansukhani R, et al
    Resistance to Mycobacterium tuberculosis infection among highly TB exposed South African gold miners.
    PLoS One. 2022;17:e0265036.
    >> Share

  175. BROOKS MB, Millones AK, Puma D, Contreras C, et al
    Mapping local hot spots with routine tuberculosis data: A pragmatic approach to identify spatial variability.
    PLoS One. 2022;17:e0265826.
    >> Share

  176. MAYA TG, Komba EV, Mensah GI, Mbelele PM, et al
    Drug susceptibility profiles and factors associated with non-tuberculous mycobacteria species circulating among patients diagnosed with pulmonary tuberculosis in Tanzania.
    PLoS One. 2022;17:e0265358.
    >> Share

  177. TURIMUMAHORO P, Tucker A, Gupta AJ, Tampi RP, et al
    A cost analysis of implementing mobile health facilitated tuberculosis contact investigation in a low-income setting.
    PLoS One. 2022;17:e0265033.
    >> Share

  178. KIM SH, Park YM, Han K, Ko SH, et al
    Association of weight change following smoking cessation with the risk of tuberculosis development: A nationwide population-based cohort study.
    PLoS One. 2022;17:e0266262.
    >> Share

  179. WALLES J, Otero LG, Tesfaye F, Abera A, et al
    Tuberculosis infection and stillbirth in Ethiopia-A prospective cohort study.
    PLoS One. 2022;17:e0261972.
    >> Share

  180. VAN DE WATER BJ, Fulcher I, Cilliers S, Meyer N, et al
    Association of HIV infection and antiretroviral therapy with the occurrence of an unfavorable TB treatment outcome in a rural district hospital in Eastern Cape, South Africa: A retrospective cohort study.
    PLoS One. 2022;17:e0266082.
    >> Share

  181. TAVOSCHI L, Belardi P, Mazzilli S, Manenti F, et al
    An integrated hospital-district performance evaluation for communicable diseases in low-and middle-income countries: Evidence from a pilot in three sub-Saharan countries.
    PLoS One. 2022;17:e0266225.
    >> Share

  182. ATNAFU A, Desta K, Girma S, Hailu D, et al
    Integration of cytopathology with molecular tests to improve the lab diagnosis for TBLN suspected patients.
    PLoS One. 2022;17:e0265499.
    >> Share

  183. GEREMEW D, Geremew H, Tamir M, Adem M, et al
    Tuberculosis and isoniazid prophylaxis among adult HIV positive patients on ART in Northwest Ethiopia.
    PLoS One. 2022;17:e0266803.
    >> Share

  184. YANG J, Kim HY, Park S, Sentissi I, et al
    Cost-effectiveness of a medication event monitoring system for tuberculosis management in Morocco.
    PLoS One. 2022;17:e0267292.
    >> Share

  185. SZKWARKO D, Kim S, Carter EJ, Goldman RE, et al
    Primary care providers' and nurses' knowledge, attitudes, and skills regarding latent TB infection testing and treatment: A qualitative study from Rhode Island.
    PLoS One. 2022;17:e0267029.
    >> Share

  186. VANLEEUW L, Zembe-Mkabile W, Atkins S
    "I'm suffering for food": Food insecurity and access to social protection for TB patients and their households in Cape Town, South Africa.
    PLoS One. 2022;17:e0266356.
    >> Share

  187. MAKESWARAN P, Shah SA, Safian N, Muhamad NA, et al
    Determinants of delayed tuberculosis treatment among patients in Selangor: A study protocol.
    PLoS One. 2022;17:e0266746.
    >> Share

  188. PLASCENCIA HERNANDEZ A, Gonzalez Sanchez RM, Hernandez Canaveral II, Luevanos Velazquez A, et al
    A prevalence study in Guadalajara, Mexico, comparing tuberculin skin test and QuantiFERON-TB Gold In-Tube.
    PLoS One. 2022;17:e0264982.
    >> Share

  189. MERID MW, Muluneh AG, Kassa GM
    Alcohol drinking delays the rate of sputum smear conversion among DR-TB patients in northwest Ethiopia; A retrospective follow-up study.
    PLoS One. 2022;17:e0264852.
    >> Share

  190. DUBALE M, Tadesse M, Berhane M, Mekonnen M, et al
    Stool-based Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in children at a teaching and referral hospital in Southwest Ethiopia.
    PLoS One. 2022;17:e0267661.
    >> Share

  191. BENDER IGNACIO RA, Long J, Saha A, Nguyen FK, et al
    Mycobacterium tuberculosis infection, immune activation, and risk of HIV acquisition.
    PLoS One. 2022;17:e0267729.
    >> Share

  192. DELGADO LG, Postigo M, Cuadrado D, Gil-Casanova S, et al
    Remote analysis of sputum smears for mycobacterium tuberculosis quantification using digital crowdsourcing.
    PLoS One. 2022;17:e0268494.
    >> Share

  193. PEPIN J, Desjardins F, Carignan A, Lambert M, et al
    Impact and benefit-cost ratio of a program for the management of latent tuberculosis infection among refugees in a region of Canada.
    PLoS One. 2022;17:e0267781.
    >> Share

  194. KAZIBWE A, Oryokot B, Mugenyi L, Kagimu D, et al
    Incidence of tuberculosis among PLHIV on antiretroviral therapy who initiated isoniazid preventive therapy: A multi-center retrospective cohort study.
    PLoS One. 2022;17:e0266285.
    >> Share

  195. SALOMON A, Law S, Johnson C, Baddeley A, et al
    Interventions to improve linkage along the HIV-tuberculosis care cascades in low- and middle-income countries: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0267511.
    >> Share

  196. KATHAMUTHU GR, Sridhar R, Baskaran D, Babu S, et al
    Dominant expansion of CD4+, CD8+ T and NK cells expressing Th1/Tc1/Type 1 cytokines in culture-positive lymph node tuberculosis.
    PLoS One. 2022;17:e0269109.
    >> Share

  197. SAGHAZADEH A, Rezaei N
    Vascular endothelial growth factor levels in tuberculosis: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0268543.
    >> Share

  198. YANG DL, Li W, Pan MH, Su HX, et al
    Spatial analysis and influencing factors of pulmonary tuberculosis among students in Nanning, during 2012-2018.
    PLoS One. 2022;17:e0268472.
    >> Share

  199. READHEAD A, Flood J, Barry P
    Health insurance, healthcare utilization and language use among populations who experience risk for tuberculosis, California 2014-2017.
    PLoS One. 2022;17:e0268739.
    >> Share

  200. BAKULA Z, Wuyep VB, Bartocha L, Vyazovaya A, et al
    Molecular snapshot of drug-resistant Mycobacterium tuberculosis strains from the Plateau State, Nigeria.
    PLoS One. 2022;17:e0266837.
    >> Share

  201. KHUNDI M, Carpenter JR, Corbett EL, Feasey HRA, et al
    Neighbourhood prevalence-to-notification ratios for adult bacteriologically-confirmed tuberculosis reveals hotspots of underdiagnosis in Blantyre, Malawi.
    PLoS One. 2022;17:e0268749.
    >> Share

  202. ABEBAW Y, Kebede A, Eshetu K, Tesfaye E, et al
    Quality assurance practices in tuberculosis diagnostic health facilities in Ethiopia.
    PLoS One. 2022;17:e0269601.
    >> Share

  203. MEAZA A, Tola HH, Eshetu K, Mindaye T, et al
    Tuberculosis among refugees and migrant populations: Systematic review.
    PLoS One. 2022;17:e0268696.
    >> Share

  204. BILCHUT AH, Mekonnen AG, Assen TA
    Knowledge of symptoms and delays in diagnosis of extrapulmonary tuberculosis patients in North Shewa zone, Ethiopia.
    PLoS One. 2022;17:e0270002.
    >> Share

  205. YOUN HM, Shin MK, Jeong D, Kim HJ, et al
    Risk factors associated with tuberculosis recurrence in South Korea determined using a nationwide cohort study.
    PLoS One. 2022;17:e0268290.
    >> Share

  206. XI Y, Zhang W, Qiao RJ, Tang J, et al
    Risk factors for multidrug-resistant tuberculosis: A worldwide systematic review and meta-analysis.
    PLoS One. 2022;17:e0270003.
    >> Share

  207. MOLLA KA, Reta MA, Ayene YY
    Prevalence of multidrug-resistant tuberculosis in East Africa: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0270272.
    >> Share

  208. REN C, Tang J, Xia L
    Interferon gamma release assays for diagnosis of osteoarticular tuberculosis: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0269234.
    >> Share

  209. EVANS EE, Avaliani T, Gujabidze M, Bakuradze T, et al
    Long term outcomes of patients with tuberculous meningitis: The impact of drug resistance.
    PLoS One. 2022;17:e0270201.
    >> Share

  210. AMOUR MA, Rees CA, Munseri PJ, Said J, et al
    Serial T-SPOT.TB responses in Tanzanian adolescents: Transient, persistent and irregular conversions.
    PLoS One. 2022;17:e0268685.
    >> Share

  211. INDRATI AR, Sumarpo A, Atmadja P, Wisesa RR, et al
    Exploring alternative cytokines as potential biomarkers for latent tuberculosis infection in pregnant women.
    PLoS One. 2022;17:e0270552.
    >> Share

  212. YAMATANI I, Komiya K, Shuto H, Yamanaka M, et al
    Correlation between tuberculosis-specific interferon-gamma release assay and intrathoracic calcification: A cross-sectional study.
    PLoS One. 2022;17:e0270785.
    >> Share

  213. AMEDE PO, Adedire E, Usman A, Ameh CA, et al
    Drug-susceptible tuberculosis treatment outcomes and its associated factors among inmates in prison settings in Bauchi State, Nigeria, 2014-2018.
    PLoS One. 2022;17:e0270819.
    >> Share

  214. KHAN MK, Islam MN, Hassan J, Paul SK, et al
    Hierarchical true prevalence, risk factors and clinical symptoms of tuberculosis among suspects in Bangladesh.
    PLoS One. 2022;17:e0262978.
    >> Share

  215. WIDYANINGSIH V, Febrinasari RP, Sari V, Augustania C, et al
    Potential and challenges for an integrated management of tuberculosis, diabetes mellitus, and hypertension: A scoping review protocol.
    PLoS One. 2022;17:e0271323.
    >> Share

  216. AGGARWAL AN, Agarwal R, Dhooria S, Prasad KT, et al
    Xpert MTB/RIF Ultra versus Xpert MTB/RIF for diagnosis of tuberculous pleural effusion: A systematic review and comparative meta-analysis.
    PLoS One. 2022;17:e0268483.
    >> Share

  217. ZIKO LM, Hoffman TW, Fwoloshi S, Chanda D, et al
    Aetiology and prognosis of community-acquired pneumonia at the Adult University Teaching Hospital in Zambia.
    PLoS One. 2022;17:e0271449.
    >> Share

  218. KACZMARKOWSKA A, Didkowska A, Brzezinska S, Klich D, et al
    Could the type and severity of gross lesions in pig lymph nodes play a role in the detection of Mycobacterium avium?
    PLoS One. 2022;17:e0269912.
    >> Share

  219. LUNGU P, Mushota K, Njelesani E, Sukwa T, et al
    Expression of mycobacterium tuberculosis induced SOCS3 and STAT3 and the implications on innate immunity in TB patients vs healthy contacts in high TB/HIV endemic setting: A cross-sectional analytical study.
    PLoS One. 2022;17:e0263624.
    >> Share

  220. HANSEN J, Kolbe K, Konig IR, Scherliess R, et al
    Lipobiotin-capture magnetic bead assay for isolation, enrichment and detection of Mycobacterium tuberculosis from saliva.
    PLoS One. 2022;17:e0265554.
    >> Share

  221. WADEMAN DT, Hoddinott G, Purchase SE, Seddon JA, et al
    Practical and psychosocial challenges faced by caregivers influence the acceptability of multidrug-resistant tuberculosis preventive therapy for young children.
    PLoS One. 2022;17:e0268560.
    >> Share

  222. PERESU E, Heunis JC, Kigozi NG, De Graeve D, et al
    Knowledge, attitudes and practices of community treatment supporters administering multidrug-resistant tuberculosis injections: A cross-sectional study in rural Eswatini.
    PLoS One. 2022;17:e0271362.
    >> Share

  223. PONGPEERADECH N, Kasetchareo Y, Chuchottaworn C, Lawpoolsri S, et al
    Evaluation of the use of GeneXpert MTB/RIF in a zone with high burden of tuberculosis in Thailand.
    PLoS One. 2022;17:e0271130.
    >> Share

  224. LAHOOD A, Rahman R, McKenna L, Frick M, et al
    Comparing timelines and evidence available to support new TB, HIV, and HCV drug approvals: The same, only different.
    PLoS One. 2022;17:e0271102.
    >> Share

  225. MESFIN EA, Merker M, Beyene D, Tesfaye A, et al
    Prediction of drug resistance by Sanger sequencing of Mycobacterium tuberculosis complex strains isolated from multidrug resistant tuberculosis suspect patients in Ethiopia.
    PLoS One. 2022;17:e0271508.
    >> Share

  226. FEKADU G, Yao J, You JHS
    Bedaquiline-based treatment for extensively drug-resistant tuberculosis in South Africa: A cost-effectiveness analysis.
    PLoS One. 2022;17:e0272770.
    >> Share

  227. SADEGHI K, Poorolajal J, Doosti-Irani A
    Prevalence of modifiable risk factors of tuberculosis and their population attributable fraction in Iran: A cross-sectional study.
    PLoS One. 2022;17:e0271511.
    >> Share

  228. SENEADZA NAH, Kwara A, Lauzardo M, Prins C, et al
    Assessing risk factors for latent and active tuberculosis among persons living with HIV in Florida: A comparison of self-reports and medical records.
    PLoS One. 2022;17:e0271917.
    >> Share

  229. GETU A, Wolde HF, Animut Y, Kibret AA, et al
    Incidence and predictors of Tuberculosis among patients enrolled in Anti-Retroviral Therapy after universal test and treat program, Addis Ababa, Ethiopia. A retrospective follow -up study.
    PLoS One. 2022;17:e0272358.
    >> Share

  230. KASSA M, Desta K, Ambachew R, Gebreyohannes Z, et al
    Magnitude of Mycobacterium tuberculosis, drug resistance and associated factors among presumptive tuberculosis patients at St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.
    PLoS One. 2022;17:e0272459.
    >> Share

  231. DANESHFAR S, Khosravi AD, Hashemzadeh M
    Drug susceptibility profiling and genetic determinants of drug resistance in Mycobacterium simiae isolates obtained from regional tuberculosis reference laboratories of Iran.
    PLoS One. 2022;17:e0267320.
    >> Share

  232. ANLEY DT, Akalu TY, Merid MW, Dessie AM, et al
    Development and validation of a nomogram for the prediction of late culture conversion among multi-drug resistant tuberculosis patients in North West Ethiopia: An application of prediction modelling.
    PLoS One. 2022;17:e0272877.
    >> Share

  233. RACHOW A, Saathoff E, Mindru R, Popescu O, et al
    Diagnostic performance of the AID line probe assay in the detection of Mycobacterium tuberculosis and drug resistance in Romanian patients with presumed TB.
    PLoS One. 2022;17:e0271297.
    >> Share

  234. NIKITUSHKIN V, Shleeva M, Loginov D, Dycka F F, et al
    Shotgun proteomic profiling of dormant, 'non-culturable' Mycobacterium tuberculosis.
    PLoS One. 2022;17:e0269847.
    >> Share

  235. MIN J, Kim HW, Kang JY, Kim SK, et al
    Comparison of different regimens with or without fluoroquinolone in isoniazid-resistant tuberculosis: A multicenter cohort study.
    PLoS One. 2022;17:e0273263.
    >> Share

  236. GEBRETNSAE H, Hadgu T, Ayele BG, Abraha A, et al
    Health extension workers contribution on tuberculosis case notification in Tigray region, Northern Ethiopia: A concurrent mixed method study.
    PLoS One. 2022;17:e0271968.
    >> Share

  237. ARAIA ZZ, Kibreab F, Kibrom AA, Mebrahtu AH, et al
    Determinants of unsuccessful tuberculosis treatment outcome in Northern Red Sea region, Eritrea.
    PLoS One. 2022;17:e0273069.
    >> Share

  238. AMEDEO A, Beci G, Giglia M, Lombardi G, et al
    Evaluation of trace calls by Xpert MTB/RIF ultra for clinical management in low TB burden settings.
    PLoS One. 2022;17:e0272997.
    >> Share

  239. ACEN EL, Kateete DP, Worodria W, Olum R, et al
    Evaluation of circulating serum cathelicidin levels as a potential biomarker to discriminate between active and latent tuberculosis in Uganda.
    PLoS One. 2022;17:e0272788.
    >> Share

  240. FISCHER H, Qian L, Skarbinski J, Bruxvoort KJ, et al
    Development and validation of a prediction algorithm to identify birth in countries with high tuberculosis incidence in two large California health systems.
    PLoS One. 2022;17:e0273363.
    >> Share

  241. MINGCHAY P, Paitoonpong L, Kawkitinarong K, Ohata PJ, et al
    Tuberculosis at a university hospital, Thailand: A surprising incidence of TB among a new generation of highly exposed health care workers who may be asymptomatic.
    PLoS One. 2022;17:e0273027.
    >> Share

  242. SAELEE C, Hanthamrongwit J, Soe PT, Khaenam P, et al
    Toll-like receptor-mediated innate immune responses by recognition of the recombinant dormancy-associated Mycobacterium tuberculosis proteins Rv2659c and Rv1738.
    PLoS One. 2022;17:e0273517.
    >> Share

  243. ESMAEL A, Mihret A, Abebe T, Mussa D, et al
    Persistent expression of activation markers on Mycobacterium tuberculosis-specific CD4 T cells in smear negative TB patients.
    PLoS One. 2022;17:e0271234.
    >> Share

  244. SHI F, Qiu X, Yu M, Huang Y, et al
    Tuberculosis-specific antigen stimulated and unstimulated interferon-gamma for tuberculous meningitis diagnosis: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0273834.
    >> Share

  245. BARAL S, Rao A, Rwema JOT, Lyons C, et al
    Competing health risks associated with the COVID-19 pandemic and early response: A scoping review.
    PLoS One. 2022;17:e0273389.
    >> Share

  246. KASWASWA K, MacPherson P, Kumwenda M, Mpunga J, et al
    Effect of patient-delivered household contact tracing and prevention for tuberculosis: A household cluster-randomised trial in Malawi.
    PLoS One. 2022;17:e0269219.
    >> Share

  247. WIJAYANTI E, Bachtiar A, Achadi A, Rachmawati UA, et al
    Mobile application development for improving medication safety in tuberculosis patients: A quasi-experimental study protocol.
    PLoS One. 2022;17:e0272616.
    >> Share

  248. GETAHUN M, Blumberg HM, Ameni G, Beyene D, et al
    Minimum inhibitory concentrations of rifampin and isoniazid among multidrug and isoniazid resistant Mycobacterium tuberculosis in Ethiopia.
    PLoS One. 2022;17:e0274426.
    >> Share

  249. KATENDE KK, Amiyo MR, Nabukeera S, Mugisa I, et al
    Design, development, and testing of a voice-text mobile health application to support Tuberculosis medication adherence in Uganda.
    PLoS One. 2022;17:e0274112.
    >> Share

  250. MVELASE NR, Singh R, Swe Swe-Han K, Mlisana KP, et al
    Pyrazinamide resistance in rifampicin discordant tuberculosis.
    PLoS One. 2022;17:e0274688.
    >> Share

  251. LEDESMA JR, Lurie P, Yorlets RR, Daly G, et al
    Spurious early ecological association suggesting BCG vaccination effectiveness for COVID-19.
    PLoS One. 2022;17:e0274900.
    >> Share

  252. MISRA S, Misra N, Seepamore B, Holloway K, et al
    "I would watch her with awe as she swallowed the first handful": A qualitative study of pediatric multidrug-resistant tuberculosis experiences in Durban, South Africa.
    PLoS One. 2022;17:e0274741.
    >> Share

  253. ACHARYA S, Deshpande P, Asirvatham ES, Palkar A, et al
    Utility of the lateral flow urine lipoarabinomannan tuberculosis assay in patients with advanced HIV disease at antiretroviral therapy centres in Mumbai, India.
    PLoS One. 2022;17:e0273970.
    >> Share

  254. CANTERA JL, Lillis LM, Peck RB, Moreau E, et al
    Performance of novel antibodies for lipoarabinomannan to develop diagnostic tests for Mycobacterium tuberculosis.
    PLoS One. 2022;17:e0274415.
    >> Share

  255. ARIF S, Akhter M, Khaliq A, Akhtar MW, et al
    Fusion peptide constructs from antigens of M. tuberculosis producing high T-cell mediated immune response.
    PLoS One. 2022;17:e0271126.
    >> Share

  256. SCRIVO R, Molteni E, Castellani C, Altobelli A, et al
    Are interferon-gamma release assays reliable to detect tuberculosis infection in patients with rheumatoid arthritis treated with Janus kinase inhibitors?
    PLoS One. 2022;17:e0275329.
    >> Share

  257. HERRERA M, Keynan Y, McLaren PJ, Isaza JP, et al
    Gene expression profiling identifies candidate biomarkers for new latent tuberculosis infections. A cohort study.
    PLoS One. 2022;17:e0274257.
    >> Share

  258. GOMES I, Dong C, Vandewalle P, Khan A, et al
    Comparative assessment of the cost-effectiveness of Tuberculosis (TB) active case-finding interventions: A systematic analysis of TB REACH wave 5 projects.
    PLoS One. 2022;17:e0270816.
    >> Share

  259. ALEMAYEHU A, Kebede A, Neway S, Tesfaye E, et al
    A glimpse into the genotype and clinical importance of non tuberculous mycobacteria among pulmonary tuberculosis patients: The case of Ethiopia.
    PLoS One. 2022;17:e0275159.
    >> Share

  260. G SG, Mannam P, Kumar V, George T, et al
    Absence of posterior pituitary bright spot in adults with CNS tuberculosis: A case-control study.
    PLoS One. 2022;17:e0275460.
    >> Share

  261. MALE HERE RR, Ryan E, Breslin P, Frankena K, et al
    Revisiting the relative effectiveness of slaughterhouses in Ireland to detect tuberculosis lesions in cattle (2014-2018).
    PLoS One. 2022;17:e0275259.
    >> Share

  262. DE HAAS P, Yenew B, Diriba G, Amare M, et al
    The Simple One-step stool processing method for detection of Pulmonary tuberculosis: A study protocol to assess the robustness, stool storage conditions and sampling strategy for global implementation and scale-up.
    PLoS One. 2022;17:e0264103.
    >> Share

  263. GAUTAM US, Asrican R, Sempowski GD
    Targeted dose delivery of Mycobacterium tuberculosis in mice using silicon antifoaming agent via aerosol exposure system.
    PLoS One. 2022;17:e0276130.
    >> Share

  264. BAL C, Gompelmann D, Krebs M, Antoniewicz L, et al
    Associations of hyponatremia and SIADH with increased mortality, young age and infection parameters in patients with tuberculosis.
    PLoS One. 2022;17:e0275827.
    >> Share

  265. HOLMES RH, Sun S, Kazi S, Ranganathan S, et al
    Management of tuberculosis infection in Victorian children: A retrospective clinical audit of factors affecting treatment completion.
    PLoS One. 2022;17:e0275789.
    >> Share

  266. NYASULU PS, Ngasama E, Tamuzi JL, Sigwadhi LN, et al
    Effect of HIV status and antiretroviral treatment on treatment outcomes of tuberculosis patients in a rural primary healthcare clinic in South Africa.
    PLoS One. 2022;17:e0274549.
    >> Share

  267. MAHMUD S, Mohsin M, Irfan SH, Muyeed A, et al
    Knowledge, attitude, practices, and determinants of them toward tuberculosis among social media users in Bangladesh: A cross-sectional study.
    PLoS One. 2022;17:e0275344.
    >> Share

  268. AMIN AG, De P, Graham B, Jensen BL, et al
    Overcome low levels of detection limit and choice of antibody affects detection of lipoarabinomannan in pediatric tuberculosis.
    PLoS One. 2022;17:e0275838.
    >> Share

  269. KAKINDA M, Tugumisirize D, Nyombi A, Mugisha M, et al
    Comparison of tests done, and tuberculosis cases detected by Xpert(R) MTB/RIF and Xpert(R) MTB/RIF-Ultra in Uganda.
    PLoS One. 2022;17:e0275960.
    >> Share

  270. SANTIN M, Perez-Recio S, Grijota MD, Anibarro L, et al
    Comparison of three short-course rifamycin-based regimens for the prevention of tuberculosis in patients with end-stage kidney disease: Study protocol for a randomised clinical trial (RIFAKiD-TB trial).
    PLoS One. 2022;17:e0276387.
    >> Share

  271. AL-MUTAIRI NM, Ahmad S, Mokaddas E, Al-Hajoj S, et al
    First insights into the phylogenetic diversity of Mycobacterium tuberculosis in Kuwait and evaluation of REBA MTB-MDR assay for rapid detection of MDR-TB.
    PLoS One. 2022;17:e0276487.
    >> Share

  272. ULAIN N, Ali A, Khan M, Ullah Z, et al
    Improving diagnosis of tuberculous lymphadenitis by combination of cytomorphology and MPT64 immunostaining on cell blocks from the fine needle aspirates.
    PLoS One. 2022;17:e0276064.
    >> Share

  273. SINGH K, Kumar R, Umam F, Kapoor P, et al
    Distinct and shared B cell responses of tuberculosis patients and their household contacts.
    PLoS One. 2022;17:e0276610.
    >> Share

  274. HUANG Y, Darr CM, Gangopadhyay K, Gangopadhyay S, et al
    Applications of machine learning tools for ultra-sensitive detection of lipoarabinomannan with plasmonic grating biosensors in clinical samples of tuberculosis.
    PLoS One. 2022;17:e0275658.
    >> Share

  275. SHAMPUTA IC, Nguyen DTK, Higazy D, Abdelhadi A, et al
    Optimizing tuberculosis screening for immigrants in southern New Brunswick: A pilot study protocol.
    PLoS One. 2022;17:e0277255.
    >> Share

  276. TORNU E, Quarcoopome L
    Correlates of quality of life among persons living with tuberculosis: A cross-sectional study.
    PLoS One. 2022;17:e0277192.
    >> Share

  277. SIME T, Oljira L, Diriba A, Firdisa G, et al
    Effect of active tuberculosis on the survival of HIV-infected adult patients who initiated antiretroviral therapy at public hospitals of Eastern Ethiopia: A retrospective cohort study.
    PLoS One. 2022;17:e0277021.
    >> Share

  278. KIM HB, Bacik JP, Wu R, Jha RK, et al
    Label-free affinity screening, design and synthesis of inhibitors targeting the Mycobacterium tuberculosis L-alanine dehydrogenase.
    PLoS One. 2022;17:e0277670.
    >> Share

  279. MESHESHA MD
    Predictors of sputum culture conversion time among MDR/RR TB patients on treatment in a low-income setting.
    PLoS One. 2022;17:e0277642.
    >> Share

  280. BAIRD K, Said H, Koornhof HJ, Duse AG, et al
    Tuberculosis control at a South African correctional centre: Diagnosis, treatment and strain characterisation.
    PLoS One. 2022;17:e0277459.
    >> Share


  281. Expression of Concern: Secretory Phosphatases Deficient Mutant of Mycobacterium tuberculosis Imparts Protection at the Primary Site of Infection in Guinea Pigs.
    PLoS One. 2022;17:e0277782.
    >> Share

  282. COCCIA M, Burny W, Demoitie MA, Gillard P, et al
    Subsequent AS01-adjuvanted vaccinations induce similar transcriptional responses in populations with different disease statuses.
    PLoS One. 2022;17:e0276505.
    >> Share

  283. RODRIGUEZ CA, Lodi S, Horsburgh CR, Bastard M, et al
    Selection bias in multidrug-resistant tuberculosis cohort studies assessing sputum culture conversion.
    PLoS One. 2022;17:e0276457.
    >> Share

  284. HUDDART S, Geocaniga-Gaviola DM, Crowder R, Lim AR, et al
    Adherence trajectory as an on-treatment risk indicator among drug-resistant TB patients in the Philippines.
    PLoS One. 2022;17:e0277078.
    >> Share

  285. DIRIBA G, Alemu A, Eshetu K, Yenew B, et al
    Bacteriologically confirmed extrapulmonary tuberculosis and the associated risk factors among extrapulmonary tuberculosis suspected patients in Ethiopia: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0276701.
    >> Share

  286. ABAYNEH M, Teressa M
    Detection of Mycobacterium tuberculosis using Gene Xpert-MTB/RIF assay among tuberculosis suspected patients at Mizan-Tepi university teaching hospital, southwest Ethiopia: An institution based cross-sectional study.
    PLoS One. 2022;17:e0277536.
    >> Share

  287. MEIER S, Seddon JA, Maasdorp E, Kleynhans L, et al
    Neutrophil degranulation, NETosis and platelet degranulation pathway genes are co-induced in whole blood up to six months before tuberculosis diagnosis.
    PLoS One. 2022;17:e0278295.
    >> Share

  288. ALEMU A, Bitew ZW, Seid G, Diriba G, et al
    Tuberculosis in individuals who recovered from COVID-19: A systematic review of case reports.
    PLoS One. 2022;17:e0277807.
    >> Share

  289. KHAMIS KM, Kadir Shahar H, Abdul Manaf R, Hamdan HM, et al
    Effectiveness of education intervention of tuberculosis treatment adherence in Khartoum State: A study protocol for a randomized control trial.
    PLoS One. 2022;17:e0277888.
    >> Share

  290. FOSTER J, Mendez D, Marais BJ, Peniyamina D, et al
    Predictors of unfavourable treatment outcome in patients diagnosed with drug-resistant tuberculosis in the Torres Strait / Papua New Guinea border region.
    PLoS One. 2022;17:e0266436.
    >> Share

  291. KISAMBA H, Kirirabwa NS, Mutesasira K, Dejene S, et al
    Tuberculosis yield among contacts of non-pulmonary bacteriologically confirmed index TB patients in the urban setting of central Uganda.
    PLoS One. 2022;17:e0278851.
    >> Share

  292. SAINI V, Debnath SK, Maske P, Dighe V, et al
    Targeted delivery of ursolic acid and oleanolic acid to lungs in the form of an inhaler for the management of tuberculosis: Pharmacokinetic and toxicity assessment.
    PLoS One. 2022;17:e0278103.
    >> Share

  293. BASHIR S, Kik SV, Ruhwald M, Khan A, et al
    Economic analysis of different throughput scenarios and implementation strategies of computer-aided detection software as a screening and triage test for pulmonary TB.
    PLoS One. 2022;17:e0277393.
    >> Share

  294. AKALU GT, Tessema B, Petros B
    High proportion of RR-TB and mutations conferring RR outside of the RRDR of the rpoB gene detected in GeneXpert MTB/RIF assay positive pulmonary tuberculosis cases, in Addis Ababa, Ethiopia.
    PLoS One. 2022;17:e0277145.
    >> Share

  295. LUCZYNSKI P, Poulin P, Romanowski K, Johnston JC, et al
    Tuberculosis and risk of cancer: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0278661.
    >> Share

  296. KIM TO, Na YO, Park HK, Lee JK, et al
    Usefulness of Mycobacterium tuberculosis-polymerase chain reaction with bronchial washing samples in predicting discontinuation of airborne infection isolation in patients hospitalized with suspected pulmonary tuberculosis.
    PLoS One. 2022;17:e0279256.
    >> Share

  297. VERBOVEN L, Phelan J, Heupink TH, Van Rie A, et al
    TBProfiler for automated calling of the association with drug resistance of variants in Mycobacterium tuberculosis.
    PLoS One. 2022;17:e0279644.
    >> Share

  298. FEYISA JW, Lemu JC, Hunde MD, Berhanu RD, et al
    Why health system diagnosis delay among tuberculosis patients in Illubabor, Oromia region, South West Ethiopia? A qualitative study.
    PLoS One. 2022;17:e0278592.
    >> Share

    January 2021
  299. AHMAD N, Baharom M, Aizuddin AN, Ramli R, et al
    Sex-related differences in smear-positive pulmonary tuberculosis patients in Kuala Lumpur, Malaysia: Prevalence and associated factors.
    PLoS One. 2021;16:e0245304.
    >> Share

  300. HASSUNA NA, El Feky M, Hussein AARM, Mahmoud MA, et al
    Interleukin-18 and interferon-gamma single nucleotide polymorphisms in Egyptian patients with tuberculosis.
    PLoS One. 2021;16:e0244949.
    >> Share

  301. MARIN AV, Rastogi N, Couvin D, Mape V, et al
    First approach to the population structure of Mycobacterium tuberculosis complex in the indigenous population in Puerto Narino-Amazonas, Colombia.
    PLoS One. 2021;16:e0245084.
    >> Share

  302. KIM J, Park BG, Lim DH, Jang WS, et al
    Development and evaluation of a multiplex loop-mediated isothermal amplification (LAMP) assay for differentiation of Mycobacterium tuberculosis and non-tuberculosis mycobacterium in clinical samples.
    PLoS One. 2021;16:e0244753.
    >> Share

  303. SHANKAR S U, Kumar AMV, Venkateshmurthy NS, Nair D, et al
    Implementation of the new integrated algorithm for diagnosis of drug-resistant tuberculosis in Karnataka State, India: How well are we doing?
    PLoS One. 2021;16:e0244785.
    >> Share

  304. ASEMAHAGN MA, Alene GD, Yimer SA
    Spatial-temporal clustering of notified pulmonary tuberculosis and its predictors in East Gojjam Zone, Northwest Ethiopia.
    PLoS One. 2021;16:e0245378.
    >> Share

  305. KHALIQ A, Ravindran R, Afzal S, Jena PK, et al
    Gut microbiome dysbiosis and correlation with blood biomarkers in active-tuberculosis in endemic setting.
    PLoS One. 2021;16:e0245534.
    >> Share

  306. THAYER MB, Parish T
    Phenoxyalkylimidazoles with an oxadiazole moiety are subject to efflux in Mycobacterium tuberculosis.
    PLoS One. 2021;16:e0239353.
    >> Share

  307. OLADIMEJI O, Adepoju V, Anyiam FE, San JE, et al
    Treatment outcomes of drug susceptible Tuberculosis in private health facilities in Lagos, South-West Nigeria.
    PLoS One. 2021;16:e0244581.
    >> Share

  308. ARNOLD ME, Courcier EA, Stringer LA, McCormick CM, et al
    A Bayesian analysis of a Test and Vaccinate or Remove study to control bovine tuberculosis in badgers (Meles meles).
    PLoS One. 2021;16:e0246141.
    >> Share

  309. CHUNG HS, Bae S, Kim I, Ahn HY, et al
    Unexpected exposure to Mycobacterium tuberculosis during bronchoscopy using radial probe endobronchial ultrasound.
    PLoS One. 2021;16:e0246371.
    >> Share

  310. DAGNE B, Desta K, Fekade R, Amare M, et al
    The Epidemiology of first and second-line drug-resistance Mycobacterium tuberculosis complex common species: Evidence from selected TB treatment initiating centers in Ethiopia.
    PLoS One. 2021;16:e0245687.
    >> Share

  311. LOPEZ K, Arriaga MB, Aliaga JG, Barreda NN, et al
    Dysglycemia is associated with Mycobacterium tuberculosis lineages in tuberculosis patients of North Lima-Peru.
    PLoS One. 2021;16:e0243184.
    >> Share

  312. SORSA A, Kaso M
    Diagnostic performance of GeneXpert in tuberculosis-HIV co-infected patients at Asella Teaching and Referral Hospital, Southeastern Ethiopia: A cross sectional study.
    PLoS One. 2021;16:e0242205.
    >> Share

  313. XIA T, Chen J, Rui J, Li J, et al
    What affected Chinese parents' decisions about tuberculosis (TB) treatment: Implications based on a cross-sectional survey.
    PLoS One. 2021;16:e0245691.
    >> Share

  314. GAUTAM N, Karki RR, Khanam R
    Knowledge on tuberculosis and utilization of DOTS service by tuberculosis patients in Lalitpur District, Nepal.
    PLoS One. 2021;16:e0245686.
    >> Share

  315. LIM RK, Semitala FC, Atuhumuza E, Sabiti L, et al
    Patient choice improves self-efficacy and intention to complete tuberculosis preventive therapy in a routine HIV program setting in Uganda.
    PLoS One. 2021;16:e0246113.
    >> Share

  316. SHIN HJ, Chang JS, Kim MS, Koh BG, et al
    Hypersensitivity reactions to multiple anti-tuberculosis drugs.
    PLoS One. 2021;16:e0246291.
    >> Share

  317. KHAN MS, Rego S, Rajal JB, Bond V, et al
    Mitigating the impact of COVID-19 on tuberculosis and HIV services: A cross-sectional survey of 669 health professionals in 64 low and middle-income countries.
    PLoS One. 2021;16:e0244936.
    >> Share

  318. DE MENDONCA EB, Schmaltz CA, Sant'Anna FM, Vizzoni AG, et al
    Anemia in tuberculosis cases: A biomarker of severity?
    PLoS One. 2021;16:e0245458.
    >> Share

  319. SOEROTO AY, Pratiwi C, Santoso P, Lestari BW, et al
    Factors affecting outcome of longer regimen multidrug-resistant tuberculosis treatment in West Java Indonesia: A retrospective cohort study.
    PLoS One. 2021;16:e0246284.
    >> Share

  320. YUEN CM, Millones AK, Puma D, Jimenez J, et al
    Closing delivery gaps in the treatment of tuberculosis infection: Lessons from implementation research in Peru.
    PLoS One. 2021;16:e0247411.
    >> Share

  321. KASSA GM, Merid MW, Muluneh AG, Wolde HF, et al
    Comparing the impact of genotypic based diagnostic algorithm on time to treatment initiation and treatment outcomes among drug-resistant tuberculosis patients in Amhara region, Ethiopia.
    PLoS One. 2021;16:e0246938.
    >> Share

  322. NAZNEEN A, Tarannum S, Chowdhury KIA, Islam MT, et al
    Implementation status of national tuberculosis infection control guidelines in Bangladeshi hospitals.
    PLoS One. 2021;16:e0246923.
    >> Share

  323. EDWARDS BD, Edwards J, Cooper R, Kunimoto D, et al
    Rifampin-resistant/multidrug-resistant Tuberculosis in Alberta, Canada: Epidemiology and treatment outcomes in a low-incidence setting.
    PLoS One. 2021;16:e0246993.
    >> Share

  324. ISLAM MN, Khan MK, Khan MFR, Kostoulas P, et al
    Risk factors and true prevalence of bovine tuberculosis in Bangladesh.
    PLoS One. 2021;16:e0247838.
    >> Share

  325. HENNEBERG M, Holloway-Kew K, Lucas T
    Human major infections: Tuberculosis, treponematoses, leprosy-A paleopathological perspective of their evolution.
    PLoS One. 2021;16:e0243687.
    >> Share

  326. FANG Y, Ma Y, Lu Q, Sun J, et al
    An outbreak of pulmonary tuberculosis and a follow-up investigation of latent tuberculosis in a high school in an eastern city in China, 2016-2019.
    PLoS One. 2021;16:e0247564.
    >> Share

  327. LAZARUS G, Tjoa K, Iskandar AWB, Louisa M, et al
    The effect of human immunodeficiency virus infection on adverse events during treatment of drug-resistant tuberculosis: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0248017.
    >> Share

  328. LANDSMAN D, Abdelbasit A, Wang C, Guerzhoy M, et al
    Cohort profile: St. Michael's Hospital Tuberculosis Database (SMH-TB), a retrospective cohort of electronic health record data and variables extracted using natural language processing.
    PLoS One. 2021;16:e0247872.
    >> Share

  329. TOMAZ APO, Raboni SM, Kussen GMB, da Silva Nogueira K, et al
    The Xpert(R) MTB/RIF diagnostic test for pulmonary and extrapulmonary tuberculosis in immunocompetent and immunocompromised patients: Benefits and experiences over 2 years in different clinical contexts.
    PLoS One. 2021;16:e0247185.
    >> Share

  330. BIERMANN O, Kluppelberg R, Lonnroth K, Viney K, et al
    'A double-edged sword': Perceived benefits and harms of active case-finding for people with presumptive tuberculosis and communities-A qualitative study based on expert interviews.
    PLoS One. 2021;16:e0247568.
    >> Share

  331. BALDWIN SL, Reese VA, Larsen SE, Beebe E, et al
    Prophylactic efficacy against Mycobacterium tuberculosis using ID93 and lipid-based adjuvant formulations in the mouse model.
    PLoS One. 2021;16:e0247990.
    >> Share

  332. HOHLFELD ASJ, Mathebula L, Pienaar ED, Abrams A, et al
    Tuberculosis treatment intervention trials in Africa: A cross-sectional bibliographic study and spatial analysis.
    PLoS One. 2021;16:e0248621.
    >> Share

  333. OHENE SA, Bonsu F, Adusi-Poku Y, Dzata F, et al
    Case finding of tuberculosis among mining communities in Ghana.
    PLoS One. 2021;16:e0248718.
    >> Share

  334. SMITH GC, Budgey R
    Simulating the next steps in badger control for bovine tuberculosis in England.
    PLoS One. 2021;16:e0248426.
    >> Share

  335. ANDARGIE A, Molla A, Tadese F, Zewdie S, et al
    Lost to follow-up and associated factors among patients with drug resistant tuberculosis in Ethiopia: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0248687.
    >> Share

  336. CHARLES M, Richard M, Reichler MR, Koama JB, et al
    Treatment success for patients with tuberculosis receiving care in areas severely affected by Hurricane Matthew - Haiti, 2016.
    PLoS One. 2021;16:e0247750.
    >> Share

  337. AMEKE S, Asare P, Aboagye SY, Otchere ID, et al
    Molecular epidemiology of Mycobacterium tuberculosis complex in the Volta Region of Ghana.
    PLoS One. 2021;16:e0238898.
    >> Share

  338. ROSENFELD G, Gabrielian A, Wang Q, Gu J, et al
    Radiologist observations of computed tomography (CT) images predict treatment outcome in TB Portals, a real-world database of tuberculosis (TB) cases.
    PLoS One. 2021;16:e0247906.
    >> Share

  339. ABDU M, Ali Y, Anteneh S, Yesuf M, et al
    Determinant factors for the occurrence of tuberculosis after initiation of antiretroviral treatment among adult patients living with HIV at Dessie Referral Hospital, South Wollo, Northeast Ethiopia, 2020. A case-control study.
    PLoS One. 2021;16:e0248490.
    >> Share

  340. HUDDART S, Singh M, Jha N, Benedetti A, et al
    Case fatality and recurrent tuberculosis among patients managed in the private sector: A cohort study in Patna, India.
    PLoS One. 2021;16:e0249225.
    >> Share

  341. HAN WM, Mahikul W, Pouplin T, Lawpoolsri S, et al
    Assessing the impacts of short-course multidrug-resistant tuberculosis treatment in the Southeast Asia Region using a mathematical modeling approach.
    PLoS One. 2021;16:e0248846.
    >> Share

  342. HERMAN B, Sirichokchatchawan W, Pongpanich S, Nantasenamat C, et al
    Development and performance of CUHAS-ROBUST application for pulmonary rifampicin-resistance tuberculosis screening in Indonesia.
    PLoS One. 2021;16:e0249243.
    >> Share

  343. HEFFERNAN C, Paulsen C, Asadi L, Egedahl ML, et al
    Individual and public health consequences associated with a missed diagnosis of pulmonary tuberculosis in the emergency department: A retrospective cohort study.
    PLoS One. 2021;16:e0248493.
    >> Share

  344. WOLDESEMAYAT EM, Azeze Z
    Treatment outcome of tuberculosis at Dilla Referral Hospital, Gedeo Zone, southern Ethiopia: A retrospective study.
    PLoS One. 2021;16:e0249369.
    >> Share

  345. MIRZAZADEH A, Kahn JG, Haddad MB, Hill AN, et al
    State-level prevalence estimates of latent tuberculosis infection in the United States by medical risk factors, demographic characteristics and nativity.
    PLoS One. 2021;16:e0249012.
    >> Share

  346. STEFANESCU S, Cocos R, Turcu-Stiolica A, Mahler B, et al
    Evaluation of prognostic significance of hematological profiles after the intensive phase treatment in pulmonary tuberculosis patients from Romania.
    PLoS One. 2021;16:e0249301.
    >> Share

  347. XU F, Tian L, Li Y, Zhang X, et al
    High prevalence of extrapulmonary tuberculosis in dairy farms: Evidence for possible gastrointestinal transmission.
    PLoS One. 2021;16:e0249341.
    >> Share

  348. DE MENDONCA EB, Schmaltz CA, Sant'Anna FM, Vizzoni AG, et al
    Correction: Anemia in tuberculosis cases: A biomarker of severity?
    PLoS One. 2021;16:e0249545.
    >> Share

  349. THIEL BA, Worodria W, Nalukwago S, Nsereko M, et al
    Immune cells in bronchoalveolar lavage fluid of Ugandan adults who resist versus those who develop latent Mycobacterium tuberculosis infection.
    PLoS One. 2021;16:e0249477.
    >> Share

  350. SANTOS FLD, Souza LLL, Bruce ATI, Crispim JA, et al
    Patients' perceptions regarding multidrug-resistant tuberculosis and barriers to seeking care in a priority city in Brazil during COVID-19 pandemic: A qualitative study.
    PLoS One. 2021;16:e0249822.
    >> Share

  351. HEWAGE S, Somasundaram N, Ratnasamy V, Ranathunga I, et al
    Active screening of patients with diabetes mellitus for pulmonary tuberculosis in a tertiary care hospital in Sri Lanka.
    PLoS One. 2021;16:e0249787.
    >> Share

  352. MEKKAOUI L, Hallin M, Mouchet F, Payen MC, et al
    Performance of Xpert MTB/RIF Ultra for diagnosis of pulmonary and extra-pulmonary tuberculosis, one year of use in a multi-centric hospital laboratory in Brussels, Belgium.
    PLoS One. 2021;16:e0249734.
    >> Share

  353. GWITIRA I, Karumazondo N, Shekede MD, Sandy C, et al
    Spatial patterns of pulmonary tuberculosis (TB) cases in Zimbabwe from 2015 to 2018.
    PLoS One. 2021;16:e0249523.
    >> Share

  354. JAKHAR S, Sakamuri R, Vu D, Dighe P, et al
    Interaction of amphiphilic lipoarabinomannan with host carrier lipoproteins in tuberculosis patients: Implications for blood-based diagnostics.
    PLoS One. 2021;16:e0243337.
    >> Share

  355. SPEKKER O, Kis L, Deak A, Makai E, et al
    An unusual case of childhood osteoarticular tuberculosis from the Arpadian Age cemetery of Gyorszentivan-Revhegyi tag (Gyor-Moson-Sopron county, Hungary).
    PLoS One. 2021;16:e0249939.
    >> Share

  356. CHAVES-TORRES NM, Fadul S, Patino J, Netto E, et al
    Factors associated with unfavorable treatment outcomes in patients with rifampicin-resistant tuberculosis in Colombia 2013-2015: A retrospective cohort study.
    PLoS One. 2021;16:e0249565.
    >> Share

  357. MCCALLAN L, Brooks C, Barry C, Couzens C, et al
    Serological test performance for bovine tuberculosis in cattle from herds with evidence of on-going infection in Northern Ireland.
    PLoS One. 2021;16:e0245655.
    >> Share

  358. RAISANEN PE, Haanpera M, Soini H, Ruutu P, et al
    Transmission of tuberculosis between foreign-born and Finnish-born populations in Finland, 2014-2017.
    PLoS One. 2021;16:e0250674.
    >> Share

  359. CARTER BB, Zhang Y, Zou H, Zhang C, et al
    Survival analysis of patients with tuberculosis and risk factors for multidrug-resistant tuberculosis in Monrovia, Liberia.
    PLoS One. 2021;16:e0249474.
    >> Share

  360. SAKTIAWATI AMI, Triyana K, Wahyuningtias SD, Dwihardiani B, et al
    eNose-TB: A trial study protocol of electronic nose for tuberculosis screening in Indonesia.
    PLoS One. 2021;16:e0249689.
    >> Share

  361. OLIVEIRA O, Gaio R, Correia-Neves M, Rito T, et al
    Evaluation of drug-resistant tuberculosis treatment outcome in Portugal, 2000-2016.
    PLoS One. 2021;16:e0250028.
    >> Share

  362. COLY S, Garrido M, Abrial D, Yao AF, et al
    Bayesian hierarchical models for disease mapping applied to contagious pathologies.
    PLoS One. 2021;16:e0222898.
    >> Share

  363. MINJA LT, Hella J, Mbwambo J, Nyandindi C, et al
    High burden of tuberculosis infection and disease among people receiving medication-assisted treatment for substance use disorder in Tanzania.
    PLoS One. 2021;16:e0250038.
    >> Share

  364. HO LJ, Yang HY, Chung CH, Chang WC, et al
    Increased risk of secondary lung cancer in patients with tuberculosis: A nationwide, population-based cohort study.
    PLoS One. 2021;16:e0250531.
    >> Share

  365. NGUYEN LH, Tran PTM, Dam TA, Forse RJ, et al
    Assessing private provider perceptions and the acceptability of video observed treatment technology for tuberculosis treatment adherence in three cities across Viet Nam.
    PLoS One. 2021;16:e0250644.
    >> Share

  366. BIGIO J, Kohli M, Klinton JS, MacLean E, et al
    Diagnostic accuracy of point-of-care ultrasound for pulmonary tuberculosis: A systematic review.
    PLoS One. 2021;16:e0251236.
    >> Share

  367. WOLDEYOHANNES D, Tekalegn Y, Sahiledengle B, Assefa T, et al
    Predictors of mortality and loss to follow-up among drug resistant tuberculosis patients in Oromia Hospitals, Ethiopia: A retrospective follow-up study.
    PLoS One. 2021;16:e0250804.
    >> Share

  368. SCHRAMM B, Nganaboy RC, Uwiragiye P, Mukeba D, et al
    Potential value of urine lateral-flow lipoarabinomannan (LAM) test for diagnosing tuberculosis among severely acute malnourished children.
    PLoS One. 2021;16:e0250933.
    >> Share

  369. JARSBERG LG, Kedia K, Wendler J, Wright AT, et al
    Nutritional markers and proteome in patients undergoing treatment for pulmonary tuberculosis differ by geographic region.
    PLoS One. 2021;16:e0250586.
    >> Share

  370. NERLICH AG, Kirchhoff SM, Panzer S, Lehn C, et al
    Chronic active non-lethal human-type tuberculosis in a high royal Bavarian officer of Napoleonic times-a mummy study.
    PLoS One. 2021;16:e0249955.
    >> Share

  371. LEE HN, Kim JI, Kim YH
    Clinical and CT characteristics of Xpert MTB/RIF-negative pulmonary tuberculosis.
    PLoS One. 2021;16:e0250616.
    >> Share

  372. JADHAV R, Gallardo-Macias R, Kumar G, Daher SS, et al
    Assessment of carbapenems in a mouse model of Mycobacterium tuberculosis infection.
    PLoS One. 2021;16:e0249841.
    >> Share

  373. KABUGO J, Namutebi J, Mujuni D, Nsawotebba A, et al
    Implementation of GeneXpert MTB/Rif proficiency testing program: A Case of the Uganda national tuberculosis reference laboratory/supranational reference laboratory.
    PLoS One. 2021;16:e0251691.
    >> Share

  374. ROBSKY KO, Isooba D, Nakasolya O, Mukiibi J, et al
    Characterization of geographic mobility among participants in facility- and community-based tuberculosis case finding in urban Uganda.
    PLoS One. 2021;16:e0251806.
    >> Share

  375. FOSTER N, Cunnama L, McCarthy K, Ramma L, et al
    Strengthening health systems to improve the value of tuberculosis diagnostics in South Africa: A cost and cost-effectiveness analysis.
    PLoS One. 2021;16:e0251547.
    >> Share

  376. ARAYA BT, Ali KE, Geleta DA, Tekele SG, et al
    Performance of the Abbott RealTime MTB and RIF/INH resistance assays for the detection of Mycobacterium Tuberculosis and resistance markers in sputum specimens.
    PLoS One. 2021;16:e0251602.
    >> Share

  377. KABIR S, Parash MTH, Emran NA, Hossain ABMT, et al
    Diagnostic challenges and Gene-Xpert utility in detecting Mycobacterium tuberculosis among suspected cases of Pulmonary tuberculosis.
    PLoS One. 2021;16:e0251858.
    >> Share

  378. HIRSCH-MOVERMAN Y, Howard AA, Mantell JE, Lebelo L, et al
    Improving child tuberculosis contact identification and screening in Lesotho: Results from a mixed-methods cluster-randomized implementation science study.
    PLoS One. 2021;16:e0248516.
    >> Share

  379. WOOD RC, Andama A, Hermansky G, Burkot S, et al
    Characterization of oral swab samples for diagnosis of pulmonary tuberculosis.
    PLoS One. 2021;16:e0251422.
    >> Share

  380. BERRA TZ, Gomes D, Ramos ACV, Alves YM, et al
    Effectiveness and trend forecasting of tuberculosis diagnosis after the introduction of GeneXpert in a city in south-eastern Brazil.
    PLoS One. 2021;16:e0252375.
    >> Share

  381. VASANTHA M, Muniyandi M, Ponnuraja C, Srinivasan R, et al
    Bayesian structural equation modeling for post treatment health related quality of life among tuberculosis patients.
    PLoS One. 2021;16:e0252205.
    >> Share

  382. SHIFERAW MB, Sinishaw MA, Amare D, Alem G, et al
    Prevalence of active tuberculosis disease among healthcare workers and support staff in healthcare settings of the Amhara region, Ethiopia.
    PLoS One. 2021;16:e0253177.
    >> Share

  383. YANG H, Yang Y, Hu ZD, Xia L, et al
    High rate of completion for weekly rifapentine plus isoniazid treatment in Chinese children with latent tuberculosis infection-A single center study.
    PLoS One. 2021;16:e0253159.
    >> Share

  384. SINGPANOMCHAI N, Akeda Y, Tomono K, Tamaru A, et al
    Rapid detection of multidrug-resistant tuberculosis based on allele-specific recombinase polymerase amplification and colorimetric detection.
    PLoS One. 2021;16:e0253235.
    >> Share

  385. SYLVERKEN AA, Kwarteng A, Twumasi-Ankrah S, Owusu M, et al
    The burden of drug resistance tuberculosis in Ghana; results of the First National Survey.
    PLoS One. 2021;16:e0252819.
    >> Share

  386. ARCENCIO RA, Berra TZ, Terena NFM, Rocha MP, et al
    Spatial clustering and temporal trend analysis of international migrants diagnosed with tuberculosis in Brazil.
    PLoS One. 2021;16:e0252712.
    >> Share

  387. JEREMIAH K, Lyimo E, Ritz C, PrayGod G, et al
    Prevalence of Mycobacterium tuberculosis infection as measured by the QuantiFERON-TB Gold assay and ESAT-6 free IGRA among adolescents in Mwanza, Tanzania.
    PLoS One. 2021;16:e0252808.
    >> Share


  388. Retraction: The Clinical Outcomes of Surgical Treatment of Noncontiguous Spinal Tuberculosis: A Retrospective Study in 23 Cases.
    PLoS One. 2021;16:e0253035.
    >> Share

  389. THOMAS BE, Thiruvengadam K, Vedhachalam C, A S, et al
    Prevalence of pulmonary tuberculosis among the tribal populations in India.
    PLoS One. 2021;16:e0251519.
    >> Share

  390. QADER GQ, Seddiq MK, Rashidi KM, Manzoor L, et al
    Prevalence of latent tuberculosis infection among health workers in Afghanistan: A cross-sectional study.
    PLoS One. 2021;16:e0252307.
    >> Share

  391. MUSAKWA NO, Bor J, Nattey C, Lonnermark E, et al
    Perceived barriers to the uptake of health services among first-year university students in Johannesburg, South Africa.
    PLoS One. 2021;16:e0245427.
    >> Share

  392. WOLDU HG, Zalwango S, Martinez L, Castellanos ME, et al
    Defining an intermediate category of tuberculin skin test: A mixture model analysis of two high-risk populations from Kampala, Uganda.
    PLoS One. 2021;16:e0245328.
    >> Share

  393. LIANG T, Chen J, Xu G, Zhang Z, et al
    Immune status changing helps diagnose osteoarticular tuberculosis.
    PLoS One. 2021;16:e0252875.
    >> Share

  394. OSMAN M, Meehan SA, von Delft A, Du Preez K, et al
    Early mortality in tuberculosis patients initially lost to follow up following diagnosis in provincial hospitals and primary health care facilities in Western Cape, South Africa.
    PLoS One. 2021;16:e0252084.
    >> Share

  395. PAN SW, Su WJ, Chan YJ, Chuang FY, et al
    Mycobacterium tuberculosis-derived circulating cell-free DNA in patients with pulmonary tuberculosis and persons with latent tuberculosis infection.
    PLoS One. 2021;16:e0253879.
    >> Share

  396. AGGARWAL AN, Agarwal R, Dhooria S, Prasad KT, et al
    Comparative accuracy of pleural fluid unstimulated interferon-gamma and adenosine deaminase for diagnosing pleural tuberculosis: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0253525.
    >> Share

  397. YU G, Shen Y, Ye B, Shi Y, et al
    Diagnostic accuracy of Mycobacterium tuberculosis cell-free DNA for tuberculosis: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0253658.
    >> Share

  398. INOUE K, Kashima S
    Association of the past epidemic of Mycobacterium tuberculosis with mortality and incidence of COVID-19.
    PLoS One. 2021;16:e0253169.
    >> Share

  399. CHAI J, Wang Q, Qin B, Wang S, et al
    Association of NOS2A gene polymorphisms with susceptibility to bovine tuberculosis in Chinese Holstein cattle.
    PLoS One. 2021;16:e0253339.
    >> Share

  400. MOHIDEM NA, Osman M, Hashim Z, Muharam FM, et al
    Association of sociodemographic and environmental factors with spatial distribution of tuberculosis cases in Gombak, Selangor, Malaysia.
    PLoS One. 2021;16:e0252146.
    >> Share

  401. LAZZARI TK, Cavalheiro E, Coutinho SE, da Silva LF, et al
    Leptin and advanced glycation end products receptor (RAGE) in tuberculosis patients.
    PLoS One. 2021;16:e0254198.
    >> Share

  402. OUDGHIRI A, Momen G, Aainouss A, Laglaoui A, et al
    Genotypic diversity of multi- and pre-extremely drug-resistant Mycobacterium tuberculosis isolates from Morocco.
    PLoS One. 2021;16:e0253826.
    >> Share

  403. ALMAW G, Conlan AJK, Ameni G, Gumi B, et al
    The variable prevalence of bovine tuberculosis among dairy herds in Central Ethiopia provides opportunities for targeted intervention.
    PLoS One. 2021;16:e0254091.
    >> Share

  404. OBSA MS, Daga WB, Wosene NG, Gebremedhin TD, et al
    Treatment seeking delay and associated factors among tuberculosis patients attending health facility in Ethiopia from 2000 to 2020: A systematic review and meta analysis.
    PLoS One. 2021;16:e0253746.
    >> Share

  405. DAWIT Z, Abebe S, Dessu S, Mesele M, et al
    Incidence and predictors of mortality among children co-infected with tuberculosis and human immunodeficiency virus at public hospitals in Southern Ethiopia.
    PLoS One. 2021;16:e0253449.
    >> Share

  406. ALEMU A, Bitew ZW, Worku T, Gamtesa DF, et al
    Predictors of mortality in patients with drug-resistant tuberculosis: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0253848.
    >> Share

  407. CRECELIUS EM, Lustik MB, Horseman TS, Jones MU, et al
    The prevalence of M. tuberculosis among acid fast bacilli cultures from military health system and veterans affairs beneficiaries in Hawaii and the Pacific Islands from 2002 to 2019.
    PLoS One. 2021;16:e0254312.
    >> Share

  408. CUONG NK, Ngoc NB, Hoa NB, Dat VQ, et al
    GeneXpert on patients with human immunodeficiency virus and smear-negative pulmonary tuberculosis.
    PLoS One. 2021;16:e0253961.
    >> Share

  409. TADOKERA R, Huo S, Theron G, Timire C, et al
    Health care seeking patterns of rifampicin-resistant tuberculosis patients in Harare, Zimbabwe: A prospective cohort study.
    PLoS One. 2021;16:e0254204.
    >> Share

  410. TANG J, Huang Y, Cai Z, Ma Y, et al
    Mycobacterial heparin-binding hemagglutinin (HBHA)-induced interferon-gamma release assay (IGRA) for discrimination of latent and active tuberculosis: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0254571.
    >> Share

  411. MAOKOLA WM, Ngowi BJ, Mahande MJ, Todd J, et al
    Impact of Isoniazid Preventive Therapy on Tuberculosis incidence among people living with HIV: A secondary data analysis using Inverse Probability Weighting of individuals attending HIV care and treatment clinics in Tanzania.
    PLoS One. 2021;16:e0254082.
    >> Share

  412. SHAYO FK, Shayo SC
    Readiness of healthcare facilities with tuberculosis services to manage diabetes mellitus in Tanzania: A nationwide analysis for evidence-informed policy-making in high burden settings.
    PLoS One. 2021;16:e0254349.
    >> Share

  413. BOAH M, Kpordoxah MR, Adokiya MN
    Self-reported gender differentials in the knowledge of tuberculosis transmission and curative possibility using national representative data in Ghana.
    PLoS One. 2021;16:e0254499.
    >> Share

  414. SAMUELS THA, Wyss R, Ongarello S, Moore DAJ, et al
    Evaluation of the diagnostic performance of laboratory-based c-reactive protein as a triage test for active pulmonary tuberculosis.
    PLoS One. 2021;16:e0254002.
    >> Share

  415. TAYE H, Alemu K, Mihret A, Ayalew S, et al
    Epidemiology of Mycobacterium tuberculosis lineages and strain clustering within urban and peri-urban settings in Ethiopia.
    PLoS One. 2021;16:e0253480.
    >> Share

  416. SALCEDO J, Rosales M, Kim JS, Nuno D, et al
    Cost-effectiveness of artificial intelligence monitoring for active tuberculosis treatment: A modeling study.
    PLoS One. 2021;16:e0254950.
    >> Share

  417. ARJA A, Godana W, Hassen H, Bogale B, et al
    Patient delay and associated factors among tuberculosis patients in Gamo zone public health facilities, Southern Ethiopia: An institution-based cross-sectional study.
    PLoS One. 2021;16:e0255327.
    >> Share

  418. SCORDO JM, Aguillon-Duran GP, Ayala D, Quirino-Cerrillo AP, et al
    A prospective cross-sectional study of tuberculosis in elderly Hispanics reveals that BCG vaccination at birth is protective whereas diabetes is not a risk factor.
    PLoS One. 2021;16:e0255194.
    >> Share

  419. CONNELLY JT, Andama A, Grant BD, Ball A, et al
    Field evaluation of a prototype tuberculosis lipoarabinomannan lateral flow assay on HIV-positive and HIV-negative patients.
    PLoS One. 2021;16:e0254156.
    >> Share

  420. VAN GINDERDEUREN E, Bassett J, Hanrahan CF, Mutunga L, et al
    Novel health system strategies for tuberculin skin testing at primary care clinics: Performance assessment and health economic evaluation.
    PLoS One. 2021;16:e0246523.
    >> Share

  421. IM C, Kim Y
    Spatial pattern of tuberculosis (TB) and related socio-environmental factors in South Korea, 2008-2016.
    PLoS One. 2021;16:e0255727.
    >> Share

  422. ISLAM SS, Rumi TB, Kabir SML, van der Zanden AGM, et al
    Correction: Bovine tuberculosis prevalence and risk factors in selected districts of Bangladesh.
    PLoS One. 2021;16:e0256042.
    >> Share

  423. KUMAR SK, Arya S, Singh A, Misra R, et al
    Patterns of T and B cell responses to Mycobacterium tuberculosis membrane-associated antigens and their relationship with disease activity in rheumatoid arthritis patients with latent tuberculosis infection.
    PLoS One. 2021;16:e0255639.
    >> Share

  424. ALISJAHBANA B, Koesoemadinata RC, Hadisoemarto PF, Lestari BW, et al
    Are neighbourhoods of tuberculosis cases a high-risk population for active intervention? A protocol for tuberculosis active case finding.
    PLoS One. 2021;16:e0256043.
    >> Share

  425. DHAKULKAR S, Das M, Sutar N, Oswal V, et al
    Treatment outcomes of children and adolescents receiving drug-resistant TB treatment in a routine TB programme, Mumbai, India.
    PLoS One. 2021;16:e0246639.
    >> Share

  426. FOREMAN HC, Frank A, Stedman TT
    Determination of variable region sequences from hybridoma immunoglobulins that target Mycobacterium tuberculosis virulence factors.
    PLoS One. 2021;16:e0256079.
    >> Share

  427. SCHRAMM B, Nganaboy RC, Uwiragiye P, Mukeba D, et al
    Correction: Potential value of urine lateral-flow lipoarabinomannan (LAM) test for diagnosing tuberculosis among severely acute malnourished children.
    PLoS One. 2021;16:e0256717.
    >> Share

  428. KHAN IA, Nayak B, Markandey M, Bajaj A, et al
    Differential prevalence of pathobionts and host gene polymorphisms in chronic inflammatory intestinal diseases: Crohn's disease and intestinal tuberculosis.
    PLoS One. 2021;16:e0256098.
    >> Share

  429. NATHAVITHARANA RR, van der Westhuizen A, van der Westhuizen HM, Mishra H, et al
    "If I've got latent TB, I would like to get rid of it": Derivation of the CARD (Constraints, Actions, Risks, and Desires) Framework informed by South African healthcare worker perspectives on latent tuberculosis treatment.
    PLoS One. 2021;16:e0254211.
    >> Share

  430. MURALI S, Krishnamoorthy Y, Knudsen S, Roy G, et al
    Comparison of profile and treatment outcomes between elderly and non-elderly tuberculosis patients in Puducherry and Tamil Nadu, South India.
    PLoS One. 2021;16:e0256773.
    >> Share

  431. OHARA Y, Ozeki Y, Tateishi Y, Mashima T, et al
    Correction: Significance of a histone-like protein with its native structure for the diagnosis of asymptomatic tuberculosis.
    PLoS One. 2021;16:e0256946.
    >> Share

  432. OSEI-WUSU S, Otchere ID, Morgan P, Musah AB, et al
    Genotypic and phenotypic diversity of Mycobacterium tuberculosis complex genotypes prevalent in West Africa.
    PLoS One. 2021;16:e0255433.
    >> Share

  433. CHETTY-MAKKAN CM, deSanto D, Lessells R, Charalambous S, et al
    Exploring the promise and reality of ward-based primary healthcare outreach teams conducting TB household contact tracing in three districts of South Africa.
    PLoS One. 2021;16:e0256033.
    >> Share

  434. LOXTON NW, Rohlwink UK, Tshavhungwe M, Dlamini L, et al
    A pilot study of inflammatory mediators in brain extracellular fluid in paediatric TBM.
    PLoS One. 2021;16:e0246997.
    >> Share

  435. ORESKOVIC A, Lutz BR
    Ultrasensitive hybridization capture: Reliable detection of <1 copy/mL short cell-free DNA from large-volume urine samples.
    PLoS One. 2021;16:e0247851.
    >> Share

  436. THAPA P, Jayasuriya R, Hall JJ, Beek K, et al
    Role of informal healthcare providers in tuberculosis care in low- and middle-income countries: A systematic scoping review.
    PLoS One. 2021;16:e0256795.
    >> Share

  437. KERKHOFF AD, Kagujje M, Nyangu S, Mateyo K, et al
    Pathways to care and preferences for improving tuberculosis services among tuberculosis patients in Zambia: A discrete choice experiment.
    PLoS One. 2021;16:e0252095.
    >> Share

  438. BUTTLE TS, Hummerstone CY, Billahalli T, Ward RJB, et al
    The monocyte-to-lymphocyte ratio: Sex-specific differences in the tuberculosis disease spectrum, diagnostic indices and defining normal ranges.
    PLoS One. 2021;16:e0247745.
    >> Share

  439. JO Y, Kagujje M, Johnson K, Dowdy D, et al
    Costs and cost-effectiveness of a comprehensive tuberculosis case finding strategy in Zambia.
    PLoS One. 2021;16:e0256531.
    >> Share

  440. NGOC NB, Vu Dinh H, Thuy NT, Quang DV, et al
    Active surveillance for adverse events in patients on longer treatment regimens for multidrug-resistant tuberculosis in Viet Nam.
    PLoS One. 2021;16:e0255357.
    >> Share

  441. GOTHAM D, McKenna L, Deborggraeve S, Madoori S, et al
    Public investments in the development of GeneXpert molecular diagnostic technology.
    PLoS One. 2021;16:e0256883.
    >> Share

  442. DEVALRAJU KP, Neela VSK, Krovvidi SS, Vankayalapati R, et al
    Defective expansion and function of memory like natural killer cells in HIV+ individuals with latent tuberculosis infection.
    PLoS One. 2021;16:e0257185.
    >> Share

  443. GALLUCCI G, Santucci N, Diaz A, Bongiovanni B, et al
    Increased levels of circulating LPS during Tuberculosis prevails in patients with advanced pulmonary involvement.
    PLoS One. 2021;16:e0257214.
    >> Share

  444. KIMANI E, Muhula S, Kiptai T, Orwa J, et al
    Factors influencing TB treatment interruption and treatment outcomes among patients in Kiambu County, 2016-2019.
    PLoS One. 2021;16:e0248820.
    >> Share

  445. PANRAKSA Y, Amin AG, Graham B, Henry CS, et al
    Immobilization of Proteinase K for urine pretreatment to improve diagnostic accuracy of active tuberculosis.
    PLoS One. 2021;16:e0257615.
    >> Share

  446. GOPALAN N, Srinivasalu VA, Chinnayan P, Velayutham B, et al
    Predictors of unfavorable responses to therapy in rifampicin-sensitive pulmonary tuberculosis using an integrated approach of radiological presentation and sputum mycobacterial burden.
    PLoS One. 2021;16:e0257647.
    >> Share

  447. WATURUOCHA UW, P J A, Singh KK, Malhotra V, et al
    A high-frequency single nucleotide polymorphism in the MtrB sensor kinase in clinical strains of Mycobacterium tuberculosis alters its biochemical and physiological properties.
    PLoS One. 2021;16:e0256664.
    >> Share

  448. TAMENE W, Abebe M, Wassie L, Mollalign H, et al
    PDL1 expression on monocytes is associated with plasma cytokines in Tuberculosis and HIV.
    PLoS One. 2021;16:e0258122.
    >> Share

  449. ZVONAREVA O, Witte S, Kabanets N, Filinyuk O, et al
    Adolescents in a tuberculosis hospital: Qualitative study of how relationships with doctors, caregivers, and peers mediate their mental wellbeing.
    PLoS One. 2021;16:e0257379.
    >> Share

  450. NABITY SA, Gunde LJ, Surie D, Shiraishi RW, et al
    Early-phase scale-up of isoniazid preventive therapy for people living with HIV in two districts in Malawi (2017).
    PLoS One. 2021;16:e0248115.
    >> Share

  451. DIRIBA G, Tola HH, Alemu A, Yenew B, et al
    Drug resistance and its risk factors among extrapulmonary tuberculosis in Ethiopia: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0258295.
    >> Share

  452. SANCHEZ-CORRALES L, Tovar-Aguirre OL, Galeano-Vanegas NF, Castano Jimenez PA, et al
    Phylogenomic analysis and Mycobacterium tuberculosis antibiotic resistance prediction by whole-genome sequencing from clinical isolates of Caldas, Colombia.
    PLoS One. 2021;16:e0258402.
    >> Share

  453. SUN L, Chen Y, Yi P, Yang L, et al
    Serological detection of Mycobacterium Tuberculosis complex infection in multiple hosts by One Universal ELISA.
    PLoS One. 2021;16:e0257920.
    >> Share

  454. WELEKIDAN LN, Skjerve E, Dejene TA, Gebremichael MW, et al
    Correction: Characteristics of pulmonary multidrug-resistant tuberculosis patients in Tigray Region, Ethiopia: A cross-sectional study.
    PLoS One. 2021;16:e0258457.
    >> Share

  455. DOLLA CK, Dhanaraj B, Chandrasekaran P, Selvaraj S, et al
    Prevalence of bacteriologically confirmed pulmonary tuberculosis and associated risk factors: A community survey in Thirvallur District, south India.
    PLoS One. 2021;16:e0247245.
    >> Share

  456. VON BOTH U, Gerlach P, Ritz N, Bogyi M, et al
    Management of childhood and adolescent latent tuberculous infection (LTBI) in Germany, Austria and Switzerland.
    PLoS One. 2021;16:e0250387.
    >> Share

  457. APPIAH PK, Osei B, Amu H
    Factors associated with nutritional status, knowledge and attitudes among tuberculosis patients receiving treatment in Ghana: A cross-sectional study in the Tema Metropolis.
    PLoS One. 2021;16:e0258033.
    >> Share

  458. ALI MA, Balcha ES, Woldesemayat AA, Tirore LD, et al
    Combined assessment of tuberculosis case notification rate and infection control at health facilities of Dale districts, Sidama Zone, Southern Ethiopia.
    PLoS One. 2021;16:e0242446.
    >> Share

  459. ALLIE T, Jackson A, Ambler J, Johnston K, et al
    TBDBT: A TB DataBase Template for collection of harmonized TB clinical research data in REDCap, facilitating data standardisation for inter-study comparison and meta-analyses.
    PLoS One. 2021;16:e0249165.
    >> Share

  460. SPEKKER O, Hunt DR, Berthon W, Paja L, et al
    Tracking down the White Plague. Chapter three: Revision of endocranial abnormally pronounced digital impressions as paleopathological diagnostic criteria for tuberculous meningitis.
    PLoS One. 2021;16:e0249020.
    >> Share

  461. HOFFMANN J, Chedid C, Ocheretina O, Masetti C, et al
    Drug-resistant TB prevalence study in 5 health institutions in Haiti.
    PLoS One. 2021;16:e0248707.
    >> Share

  462. SINGH AR, Kumar A, Shewade HD, Dhingra B, et al
    Poor adherence to TB diagnosis guidelines among under-five children with severe acute malnutrition in central India: A missed window of opportunity?
    PLoS One. 2021;16:e0248192.
    >> Share

  463. DAS M, Mathur T, Ravi S, Meneguim AC, et al
    Challenging drug-resistant TB treatment journey for children, adolescents and their care-givers: A qualitative study.
    PLoS One. 2021;16:e0248408.
    >> Share

  464. GEIGER K, Stamper PD, Farley JE
    The effects of MDR/RR-TB treatment on HIV disease: A systematic review of literature.
    PLoS One. 2021;16:e0248174.
    >> Share

  465. SAHILE Z, Tezera R, Haile Mariam D, Collins J, et al
    Nutritional status and TB treatment outcomes in Addis Ababa, Ethiopia: An ambi-directional cohort study.
    PLoS One. 2021;16:e0247945.
    >> Share

  466. LOVEDAY M, Hlangu S, Larkan LM, Cox H, et al
    "This is not my body": Therapeutic experiences and post-treatment health of people with rifampicin-resistant tuberculosis.
    PLoS One. 2021;16:e0251482.
    >> Share

  467. NOVIYANI A, Nopsopon T, Pongpirul K
    Variation of tuberculosis prevalence across diagnostic approaches and geographical areas of Indonesia.
    PLoS One. 2021;16:e0258809.
    >> Share

  468. MANYELO CM, Chegou NN, Seddon JA, Snyders CI, et al
    Serum and cerebrospinal fluid host proteins indicate stroke in children with tuberculous meningitis.
    PLoS One. 2021;16:e0250944.
    >> Share

  469. MICHENI LN, Kassaza K, Kinyi H, Ntulume I, et al
    Rifampicin and isoniazid drug resistance among patients diagnosed with pulmonary tuberculosis in southwestern Uganda.
    PLoS One. 2021;16:e0259221.
    >> Share

  470. BADA FO, Blok N, Okpokoro E, Dutt S, et al
    Correction: Cost comparison of nine-month treatment regimens with 20-month standardized care for the treatment of rifampicin-resistant/multi-drug resistant tuberculosis in Nigeria.
    PLoS One. 2021;16:e0259492.
    >> Share

  471. FLORENTINI EA, Angulo N, Gilman RH, Alcantara R, et al
    Correction: Immunological detection of pyrazine-2-carboxylic acid for the detection of pyrazinamide resistance in Mycobacterium tuberculosis.
    PLoS One. 2021;16:e0259439.
    >> Share

  472. CUEVAS-CORDOBA B, Fresno C, Haase-Hernandez JI, Barbosa-Amezcua M, et al
    A bioinformatics pipeline for Mycobacterium tuberculosis sequencing that cleans contaminant reads from sputum samples.
    PLoS One. 2021;16:e0258774.
    >> Share

  473. KASO AW, Hailu A
    Costs and cost-effectiveness of Gene Xpert compared to smear microscopy for the diagnosis of pulmonary tuberculosis using real-world data from Arsi zone, Ethiopia.
    PLoS One. 2021;16:e0259056.
    >> Share

  474. AGGARWAL AN, Agarwal R, Dhooria S, Prasad KT, et al
    Active pulmonary tuberculosis and coronavirus disease 2019: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0259006.
    >> Share

  475. JAIN J, Jadhao P, Banait S, Salunkhe P, et al
    Diagnostic accuracy of GeneXpert MTB/RIF assay for detection of tubercular pleural effusion.
    PLoS One. 2021;16:e0251618.
    >> Share

  476. WITTE C, Fowler JH, Pfeiffer W, Hungerford LL, et al
    Social network analysis and whole-genome sequencing to evaluate disease transmission in a large, dynamic population: A study of avian mycobacteriosis in zoo birds.
    PLoS One. 2021;16:e0252152.
    >> Share

  477. YU G, Zhong F, Shen Y, Zheng H, et al
    Diagnostic accuracy of the Xpert MTB/RIF assay for tuberculous pericarditis: A protocol of systematic review and meta-analysis.
    PLoS One. 2021;16:e0252109.
    >> Share

  478. THOMAS BE, Thiruvengadam K, S R, Rani S, et al
    Understanding health care-seeking behaviour of the tribal population in India among those with presumptive TB symptoms.
    PLoS One. 2021;16:e0250971.
    >> Share

  479. GARCIA-ZAMALLOA A, Vicente D, Arnay R, Arrospide A, et al
    Diagnostic accuracy of adenosine deaminase for pleural tuberculosis in a low prevalence setting: A machine learning approach within a 7-year prospective multi-center study.
    PLoS One. 2021;16:e0259203.
    >> Share

  480. CLOETE R, Shahbaaz M, Grobbelaar M, Sampson SL, et al
    In silico repurposing of a Novobiocin derivative for activity against latency associated Mycobacterium tuberculosis drug target nicotinate-nucleotide adenylyl transferase (Rv2421c).
    PLoS One. 2021;16:e0259348.
    >> Share

  481. ASSEFA G, Desta K, Araya S, Girma S, et al
    Diagnostic efficacy of Light-Emitting Diode (LED) Fluorescence based Microscope for the diagnosis of Tuberculous lymphadenitis.
    PLoS One. 2021;16:e0255146.
    >> Share

  482. GAUGHRAN A, Mullen E, MacWhite T, Maher P, et al
    Badger territoriality maintained despite disturbance of major road construction.
    PLoS One. 2021;16:e0242586.
    >> Share

  483. SAMUELS THA, Shete PB, Ojok C, Nalugwa T, et al
    Where will it end? Pathways to care and catastrophic costs following negative TB evaluation in Uganda.
    PLoS One. 2021;16:e0253927.
    >> Share

  484. VAN GINDERDEUREN E, Bassett J, Hanrahan CF, Van Rie A, et al
    Association between monocyte-to-lymphocyte ratio and tuberculin skin test positivity in HIV-positive adults.
    PLoS One. 2021;16:e0253907.
    >> Share

  485. ACEN EL, Biraro IA, Worodria W, Joloba ML, et al
    Impact of vitamin D status and cathelicidin antimicrobial peptide on adults with active pulmonary TB globally: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0252762.
    >> Share

  486. AYABINA DV, Gomes MGM, Nguyen NV, Vo L, et al
    The impact of active case finding on transmission dynamics of tuberculosis: A modelling study.
    PLoS One. 2021;16:e0257242.
    >> Share

  487. MUFLIHAH H, Florido M, Lin LCW, Xia Y, et al
    Boosting BCG with recombinant influenza A virus tuberculosis vaccines increases pulmonary T cell responses but not protection against Mycobacterium tuberculosis infection.
    PLoS One. 2021;16:e0259829.
    >> Share

  488. PAPADOPOULOS AO, Ealand C, Gordhan BG, VanNieuwenhze M, et al
    Characterisation of a putative M23-domain containing protein in Mycobacterium tuberculosis.
    PLoS One. 2021;16:e0259181.
    >> Share

  489. AMBREEN A, Tahseen S, Wali A, Jamil M, et al
    Predictors of slow clinical response and extended treatment in patients with extra-pulmonary tuberculosis in Pakistan, A hospital-based prospective study.
    PLoS One. 2021;16:e0259801.
    >> Share

  490. SULMAN S, Shahid S, Khaliq A, Ambreen A, et al
    Enhanced serodiagnostic potential of a fusion molecule consisting of Rv1793, Rv2628 and a truncated Rv2608 of Mycobacterium tuberculosis.
    PLoS One. 2021;16:e0258389.
    >> Share

  491. KATHAMUTHU GR, Moideen K, Sridhar R, Baskaran D, et al
    Reduced neutrophil granular proteins and post-treatment modulation in tuberculous lymphadenitis.
    PLoS One. 2021;16:e0253534.
    >> Share

  492. ALKABAB YMA, Biswas S, Ahmed S, Paul K, et al
    Differentiating transient from persistent diabetic range hyperglycemia in a cohort of people completing tuberculosis treatment in Dhaka, Bangladesh.
    PLoS One. 2021;16:e0260389.
    >> Share

  493. NARH-BANA SA, Kawonga M, Chirwa ED, Ibisomi L, et al
    Fidelity of implementation of TB screening guidelines by health providers at selected HIV clinics in Ghana.
    PLoS One. 2021;16:e0257486.
    >> Share

  494. YU G, Zhong F, Shen Y, Zheng H, et al
    Diagnostic accuracy of the Xpert MTB/RIF assay for tuberculous pericarditis: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0257220.
    >> Share

  495. OWUSU AY, Kushitor SB, Ofosu AA, Kushitor MK, et al
    Institutional mortality rate and cause of death at health facilities in Ghana between 2014 and 2018.
    PLoS One. 2021;16:e0256515.
    >> Share

  496. WEKUNDA PW, Aduda DSO, Guyah B
    Determinants of tuberculosis treatment interruption among patients in Vihiga County, Kenya.
    PLoS One. 2021;16:e0260669.
    >> Share

  497. GEORGHIOU SB, Alagna R, Cirillo DM, Carmona S, et al
    Equivalence of the GeneXpert System and GeneXpert Omni System for tuberculosis and rifampicin resistance detection.
    PLoS One. 2021;16:e0261442.
    >> Share

  498. EDESSA D, Adem F, Hagos B, Sisay M, et al
    Incidence and predictors of mortality among persons receiving second-line tuberculosis treatment in sub-Saharan Africa: A meta-analysis of 43 cohort studies.
    PLoS One. 2021;16:e0261149.
    >> Share

  499. FOE-ESSOMBA JR, Kenmoe S, Tchatchouang S, Ebogo-Belobo JT, et al
    Diabetes mellitus and tuberculosis, a systematic review and meta-analysis with sensitivity analysis for studies comparable for confounders.
    PLoS One. 2021;16:e0261246.
    >> Share

  500. PAUDEL S, Padmawati RS, Ghimire A, Yonzon CL, et al
    Feasibility of Find cases Actively, Separate safely and Treat effectively (FAST) strategy for early diagnosis of TB in Nepal: An implementation research.
    PLoS One. 2021;16:e0258883.
    >> Share

  501. CANIVE M, Gonzalez-Recio O, Fernandez A, Vazquez P, et al
    Identification of loci associated with susceptibility to Mycobacterium avium subsp. paratuberculosis infection in Holstein cattle using combinations of diagnostic tests and imputed whole-genome sequence data.
    PLoS One. 2021;16:e0256091.
    >> Share

  502. GINA NSV, Rasweswe MM, Moagi MM
    Standard precautions for preventing Tuberculosis and HIV: Compliance of Eswatini university student nurses.
    PLoS One. 2021;16:e0261944.
    >> Share

  503. AFUM T, Asare P, Asante-Poku A, Darko-Otchere I, et al
    Diagnosis of tuberculosis among COVID-19 suspected cases in Ghana.
    PLoS One. 2021;16:e0261849.
    >> Share

  504. MEAZA A, Tesfaye E, Mohamed Z, Zerihun B, et al
    Diagnostic accuracy of Truenat Tuberculosis and Rifampicin-Resistance assays in Addis Ababa, Ethiopia.
    PLoS One. 2021;16:e0261084.
    >> Share

  505. RIBEIRO RM, Havik PJ, Craveiro I
    The circuits of healthcare: Understanding healthcare seeking behaviour-A qualitative study with tuberculosis patients in Lisbon, Portugal.
    PLoS One. 2021;16:e0261688.
    >> Share

  506. SAHILE Z, Perimal-Lewis L, Arbon P, Maeder AJ, et al
    Protocol of a parallel group Randomized Control Trial (RCT) for Mobile-assisted Medication Adherence Support (Ma-MAS) intervention among Tuberculosis patients.
    PLoS One. 2021;16:e0261758.
    >> Share

  507. CHANIE ES, Gelaye GA, Tadesse TY, Feleke DG, et al
    Estimation of lifetime survival and predictors of mortality among TB with HIV co-infected children after test and treat strategies launched in Northwest, Ethiopia, 2021; a multicentre historical follow-up study.
    PLoS One. 2021;16:e0258964.
    >> Share

  508. VANQA N, Hoddinott G, Mbenyana B, Osman M, et al
    Linkage to TB care: A qualitative study to understand linkage from the patients' perspective in the Western Cape Province, South Africa.
    PLoS One. 2021;16:e0260200.
    >> Share

  509. DEMBELU M, Kote M, Gilano G, Mohammed T, et al
    Incidence and predictors of reoccurrence of opportunistic infection among adult HIV/AIDS patients attending ART clinic at public health facilities in Arba Minch town, southern Ethiopia: A retrospective cohort study.
    PLoS One. 2021;16:e0261454.
    >> Share

  510. RAHMAN SMM, Nasrin R, Rahman A, Ahmed S, et al
    Performance of GenoType MTBDRsl assay for detection of second-line drugs and ethambutol resistance directly from sputum specimens of MDR-TB patients in Bangladesh.
    PLoS One. 2021;16:e0261329.
    >> Share

  511. MISHRA P, Sharma RK, Yadav R, Rao VG, et al
    Reasons for loss to follow-up (LTFU) of pulmonary TB (PTB) patients: A qualitative study among Saharia, a particularly vulnerable tribal group of Madhya Pradesh, India.
    PLoS One. 2021;16:e0261152.
    >> Share

  512. LANSANG MAD, Alejandria MM, Law I, Juban NR, et al
    High TB burden and low notification rates in the Philippines: The 2016 national TB prevalence survey.
    PLoS One. 2021;16:e0252240.
    >> Share

  513. TAMUHLA T, Dave JA, Raubenheimer P, Tiffin N, et al
    Diabetes in a TB and HIV-endemic South African population: Analysis of a virtual cohort using routine health data.
    PLoS One. 2021;16:e0251303.
    >> Share

    January 2020
  514. MAIR L, Corbett EL, Feasey HRA, Kamchedzera W, et al
    Provider-initiated HIV testing and TB screening in the era of universal coverage: Are the right people being reached? A cohort study in Blantyre, Malawi.
    PLoS One. 2020;15:e0236407.
    >> Share

  515. KALRA A, Parija D, Raizada N, Sachdeva KS, et al
    Upfront Xpert MTB/RIF for diagnosis of pediatric TB-Does it work? Experience from India.
    PLoS One. 2020;15:e0236057.
    >> Share

  516. NACHER M, Adenis A, Guarmit B, Lucarelli A, et al
    What is AIDS in the Amazon and the Guianas in the 90-90-90 era?
    PLoS One. 2020;15:e0236368.
    >> Share

  517. ANKU PJ, Amo-Adjei J, Doku D, Kumi-Kyereme A, et al
    Challenges of scaling-up of TB-HIV integrated service delivery in Ghana.
    PLoS One. 2020;15:e0235843.
    >> Share

  518. SAYEDI SM, Seddiq MK, Rashidi MK, Qader G, et al
    Active household contact screening for tuberculosis and provision of isoniazid preventive therapy to under-five children in Afghanistan.
    PLoS One. 2020;15:e0240031.
    >> Share

  519. VIANA PVS, Paiva NS, Villela DAM, Bastos LS, et al
    Factors associated with death in patients with tuberculosis in Brazil: Competing risks analysis.
    PLoS One. 2020;15:e0240090.
    >> Share

  520. LINCE-DEROCHE N, Leuner R, Kgowedi S, Moolla A, et al
    Voices from the front lines: A qualitative study of integration of HIV, tuberculosis, and primary healthcare services in Johannesburg, South Africa.
    PLoS One. 2020;15:e0230849.
    >> Share

  521. KRISHNAKUMARIAMMA K, Ellappan K, Muthuraj M, Tamilarasu K, et al
    Molecular diagnosis, genetic diversity and drug sensitivity patterns of Mycobacterium tuberculosis strains isolated from tuberculous meningitis patients at a tertiary care hospital in South India.
    PLoS One. 2020;15:e0240257.
    >> Share

  522. SHIN HS, Choi DS, Na JB, Choi HY, et al
    Low pectoralis muscle index, cavitary nodule or mass and segmental to lobar consolidation as predictors of primary multidrug-resistant tuberculosis: A comparison with primary drug sensitive tuberculosis.
    PLoS One. 2020;15:e0239431.
    >> Share

  523. SALA C, Benjak A, Goletti D, Banu S, et al
    Multicenter analysis of sputum microbiota in tuberculosis patients.
    PLoS One. 2020;15:e0240250.
    >> Share

  524. TING NCH, El-Turk N, Chou MSH, Dobler CC, et al
    Patient-perceived treatment burden of tuberculosis treatment.
    PLoS One. 2020;15:e0241124.
    >> Share

  525. TAN C, Kallon II, Colvin CJ, Grant AD, et al
    Barriers and facilitators of tuberculosis infection prevention and control in low- and middle-income countries from the perspective of healthcare workers: A systematic review.
    PLoS One. 2020;15:e0241039.
    >> Share

  526. NGUIPDOP-DJOMO P, Rodrigues LC, Abubakar I, Mangtani P, et al
    Small-area level socio-economic deprivation and tuberculosis rates in England: An ecological analysis of tuberculosis notifications between 2008 and 2012.
    PLoS One. 2020;15:e0240879.
    >> Share

  527. BROOKS MB, Mitnick CD, Manjourides J
    Comparison of censoring assumptions to reduce bias in tuberculosis treatment cohort analyses.
    PLoS One. 2020;15:e0240297.
    >> Share

  528. MBUTHIA GW, Nyamogoba HDN, Chiang SS, McGarvey ST, et al
    Burden of stigma among tuberculosis patients in a pastoralist community in Kenya: A mixed methods study.
    PLoS One. 2020;15:e0240457.
    >> Share

  529. VELAYUTHAM B, Jayabal L, Watson B, Jagadeesan S, et al
    Tuberculosis screening in household contacts of pulmonary tuberculosis patients in an urban setting.
    PLoS One. 2020;15:e0240594.
    >> Share

  530. MERID MW, Muluneh AG, Yenit MK, Kassa GM, et al
    Treatment interruption and associated factors among patients registered on drug-resistant tuberculosis treatment in Amhara regional state, Ethiopia: 2010-2017.
    PLoS One. 2020;15:e0240564.
    >> Share

  531. KAGUJJE M, Chilukutu L, Somwe P, Mutale J, et al
    Active TB case finding in a high burden setting; comparison of community and facility-based strategies in Lusaka, Zambia.
    PLoS One. 2020;15:e0237931.
    >> Share

  532. ALAO MA, Maroushek SR, Chan YH, Asinobi AO, et al
    Treatment outcomes of Nigerian patients with tuberculosis: A retrospective 25-year review in a regional medical center.
    PLoS One. 2020;15:e0239225.
    >> Share

  533. RAMOS-SONO D, Laureano R, Rueda D, Gilman RH, et al
    An electrochemical biosensor for the detection of Mycobacterium tuberculosis DNA from sputum and urine samples.
    PLoS One. 2020;15:e0241067.
    >> Share

  534. BIERMANN O, Tran PB, Viney K, Caws M, et al
    Active case-finding policy development, implementation and scale-up in high-burden countries: A mixed-methods survey with National Tuberculosis Programme managers and document review.
    PLoS One. 2020;15:e0240696.
    >> Share

  535. SZIGETI R, Kellermayer D, Trakimas G, Kellermayer R, et al
    BCG epidemiology supports its protection against COVID-19? A word of caution.
    PLoS One. 2020;15:e0240203.
    >> Share

  536. SPEKKER O, Schultz M, Paja L, Varadi OA, et al
    Tracking down the White Plague. Chapter two: The role of endocranial abnormal blood vessel impressions and periosteal appositions in the paleopathological diagnosis of tuberculous meningitis.
    PLoS One. 2020;15:e0238444.
    >> Share

  537. FLORENTINI EA, Angulo N, Gilman RH, Alcantara R, et al
    Immunological detection of pyrazine-2-carboxylic acid for the detection of pyrazinamide resistance in Mycobacterium tuberculosis.
    PLoS One. 2020;15:e0241600.
    >> Share

  538. WAHEDI K, Biddle L, Bozorgmehr K
    Cost-effectiveness of targeted screening for active pulmonary tuberculosis among asylum-seekers: A modelling study with screening data from a German federal state (2002-2015).
    PLoS One. 2020;15:e0241852.
    >> Share

  539. WASIHUN AG, Dejene TA, Hailu GG
    Frequency of MTB and rifampicin resistance MTB using Xpert-MTB/RIF assay among adult presumptive tuberculosis patients in Tigray, Northern Ethiopia: A cross sectional study.
    PLoS One. 2020;15:e0240361.
    >> Share

  540. GOTHAM D, McKenna L, Frick M, Lessem E, et al
    Public investments in the clinical development of bedaquiline.
    PLoS One. 2020;15:e0239118.
    >> Share

  541. BALOGUN OS, Gao XZ, Jolayemi ET, Olaleye SA, et al
    Generalized cure rate model for infectious diseases with possible co-infections.
    PLoS One. 2020;15:e0239003.
    >> Share

  542. CHITTAMANY P, Yamanaka T, Suthepmany S, Sorsavanh T, et al
    First national tuberculosis patient cost survey in Lao People's Democratic Republic: Assessment of the financial burden faced by TB-affected households and the comparisons by drug-resistance and HIV status.
    PLoS One. 2020;15:e0241862.
    >> Share

  543. BASTOS HN, Osorio NS, Castro AG, Ramos A, et al
    Correction: A Prediction Rule to Stratify Mortality Risk of Patients with Pulmonary Tuberculosis.
    PLoS One. 2020;15:e0242455.
    >> Share

  544. ISLAM SKS, Rumi TB, Kabir SML, van der Zanden AGM, et al
    Bovine tuberculosis prevalence and risk factors in selected districts of Bangladesh.
    PLoS One. 2020;15:e0241717.
    >> Share

  545. GEZAHEGN LK, Argaw E, Assefa B, Geberesilassie A, et al
    Magnitude, outcome, and associated factors of anti-tuberculosis drug-induced hepatitis among tuberculosis patients in a tertiary hospital in North Ethiopia: A cross-sectional study.
    PLoS One. 2020;15:e0241346.
    >> Share

  546. BONNEWELL JP, Farrow L, Dicks KV, Cox GM, et al
    Geographic analysis of latent tuberculosis screening: A health system approach.
    PLoS One. 2020;15:e0242055.
    >> Share

  547. WANG N, Shewade HD, Thekkur P, Zhang H, et al
    Do electronic medication monitors improve tuberculosis treatment outcomes? Programmatic experience from China.
    PLoS One. 2020;15:e0242112.
    >> Share

  548. WIARDA JE, Boggiatto PM, Bayles DO, Waters WR, et al
    Severity of bovine tuberculosis is associated with innate immune-biased transcriptional signatures of whole blood in early weeks after experimental Mycobacterium bovis infection.
    PLoS One. 2020;15:e0239938.
    >> Share

  549. MAYITO J, Meya DB, Rhein J, Sekaggya-Wiltshire C, et al
    Utility of the monocyte to lymphocyte ratio in diagnosing latent tuberculosis among HIV-infected individuals with a negative tuberculosis symptom screen.
    PLoS One. 2020;15:e0241786.
    >> Share

  550. BADE AB, Mega TA
    Survival status and its predictors among multi-drug resistance tuberculosis treated patients in Ethiopia: Multicenter observational study.
    PLoS One. 2020;15:e0241684.
    >> Share

  551. SANOGO B, Ouermi AS, Barro M, Millogo A, et al
    Performance of a lymphocyte t interferon gamma test (Quantiferon-TB gold in tube) in the diagnosis of active tuberculosis in HIV-infected children.
    PLoS One. 2020;15:e0241789.
    >> Share

  552. DORJI T, Tshering T, Wangdi K
    Assessment of knowledge, attitude and practice on tuberculosis among teacher trainees of Samtse College of Education, Bhutan.
    PLoS One. 2020;15:e0241923.
    >> Share

  553. KUNDU J, Bakshi S, Joshi H, Bhadada SK, et al
    Proteomic profiling of peripheral blood mononuclear cells isolated from patients with tuberculosis and diabetes copathogenesis - A pilot study.
    PLoS One. 2020;15:e0233326.
    >> Share

  554. DARMA S, Ambara A, Aman AT, Annisa L, et al
    High frequency of azole resistant Candida spp. colonization among presumptive multidrug resistant tuberculosis (MDR-TB) patients.
    PLoS One. 2020;15:e0242542.
    >> Share

  555. KETEMA L, Dememew ZG, Assefa D, Gudina T, et al
    Evaluating the integration of tuberculosis screening and contact investigation in tuberculosis clinics in Ethiopia: A mixed method study.
    PLoS One. 2020;15:e0241977.
    >> Share

  556. FLINT L, Korkegian A, Parish T
    InhA inhibitors have activity against non-replicating Mycobacterium tuberculosis.
    PLoS One. 2020;15:e0239354.
    >> Share

  557. WELDEMHRET L, Hailu A, Gebremedhn G, Bekuretsion H, et al
    Blinded rechecking of sputum smear microscopy performance in public health facilities in Tigray region, Northern Ethiopia: Retrospective cross sectional study.
    PLoS One. 2020;15:e0239342.
    >> Share

  558. HORTER S, Achar J, Gray N, Parpieva N, et al
    Patient and health-care worker perspectives on the short-course regimen for treatment of drug-resistant tuberculosis in Karakalpakstan, Uzbekistan.
    PLoS One. 2020;15:e0242359.
    >> Share

  559. BANU S, Haque F, Ahmed S, Sultana S, et al
    Social Enterprise Model (SEM) for private sector tuberculosis screening and care in Bangladesh.
    PLoS One. 2020;15:e0241437.
    >> Share

  560. AJUDUA FI, Mash RJ
    Implementing active surveillance for TB-The views of managers in a resource limited setting, South Africa.
    PLoS One. 2020;15:e0239430.
    >> Share

  561. HAUK C, Schafermann S, Martus P, Muzafarova N, et al
    Quality assurance in anti-tuberculosis drug procurement by the Stop TB Partnership-Global Drug Facility: Procedures, costs, time requirements, and comparison of assay and dissolution results by manufacturers and by external analysis.
    PLoS One. 2020;15:e0243428.
    >> Share

  562. STOCKBRIDGE EL, Loethen AD, Annan E, Miller TL, et al
    Interferon gamma release assay tests are associated with persistence and completion of latent tuberculosis infection treatment in the United States: Evidence from commercial insurance data.
    PLoS One. 2020;15:e0243102.
    >> Share

  563. LI Y, Pang Y, Zhang T, Xian X, et al
    Genotypes of Mycobacterium tuberculosis isolates circulating in Shaanxi Province, China.
    PLoS One. 2020;15:e0242971.
    >> Share

  564. WANG D, Tong X, Wang L, Zhang S, et al
    The association between osteopontin and tuberculosis: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0242702.
    >> Share

  565. YU G, Zhao W, Shen Y, Zhu P, et al
    Metagenomic next generation sequencing for the diagnosis of tuberculosis meningitis: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0243161.
    >> Share

  566. BADA FO, Blok N, Okpokoro E, Dutt S, et al
    Cost comparison of nine-month treatment regimens with 20-month standardized care for the treatment of rifampicin-resistant/multi-drug resistant tuberculosis in Nigeria.
    PLoS One. 2020;15:e0241065.
    >> Share

  567. LIMSRIVILAI J, Lee CK, Prueksapanich P, Harinwan K, et al
    Validation of models using basic parameters to differentiate intestinal tuberculosis from Crohn's disease: A multicenter study from Asia.
    PLoS One. 2020;15:e0242879.
    >> Share

  568. KITONSA PJ, Nalutaaya A, Mukiibi J, Nakasolya O, et al
    Evaluation of underweight status may improve identification of the highest-risk patients during outpatient evaluation for pulmonary tuberculosis.
    PLoS One. 2020;15:e0243542.
    >> Share

  569. MOHAMMEDHUSSEIN M, Hajure M, Shifa JE, Hassen TA, et al
    Perceived stigma among patient with pulmonary tuberculosis at public health facilities in southwest Ethiopia: A cross-sectional study.
    PLoS One. 2020;15:e0243433.
    >> Share

  570. DIRIBA G, Kebede A, Tola HH, Yenew B, et al
    Molecular characterization and drug resistance patterns of Mycobacterium tuberculosis complex in extrapulmonary tuberculosis patients in Addis Ababa, Ethiopia.
    PLoS One. 2020;15:e0243493.
    >> Share

  571. KAN CK, Ragan EJ, Sarkar S, Knudsen S, et al
    Alcohol use and tuberculosis clinical presentation at the time of diagnosis in Puducherry and Tamil Nadu, India.
    PLoS One. 2020;15:e0240595.
    >> Share

  572. KOLTE IV, Pereira L, Benites A, de Sousa IMC, et al
    The contribution of stigma to the transmission and treatment of tuberculosis in a hyperendemic indigenous population in Brazil.
    PLoS One. 2020;15:e0243988.
    >> Share

  573. AREGA B, Mersha A, Minda A, Getachew Y, et al
    Epidemiology and the diagnostic challenge of extra-pulmonary tuberculosis in a teaching hospital in Ethiopia.
    PLoS One. 2020;15:e0243945.
    >> Share

  574. KOSGEI RJ, Callens S, Gichangi P, Temmerman M, et al
    Gender difference in mortality among pulmonary tuberculosis HIV co-infected adults aged 15-49 years in Kenya.
    PLoS One. 2020;15:e0243977.
    >> Share

  575. SHEN Y, Fang L, Ye B, Yu G, et al
    Meta-analysis of diagnostic accuracy of nucleic acid amplification tests for abdominal tuberculosis: A protocol.
    PLoS One. 2020;15:e0243765.
    >> Share

  576. GADICHERLA S, Krishnappa L, Madhuri B, Mitra SG, et al
    Envisioning a learning surveillance system for tuberculosis.
    PLoS One. 2020;15:e0243610.
    >> Share

  577. ALI N, Bello GL, Rossetti MLR, Krieger MA, et al
    Demonstration of a fast and easy sample-to-answer protocol for tuberculosis screening in point-of-care settings: A proof of concept study.
    PLoS One. 2020;15:e0242408.
    >> Share

  578. MEJIA-PAILLES G, Berrington A, McGrath N, Hosegood V, et al
    Trends in the prevalence and incidence of orphanhood in children and adolescents <20 years in rural KwaZulu-Natal South Africa, 2000-2014.
    PLoS One. 2020;15:e0238563.
    >> Share

  579. HOPKINS KL, Hlongwane KE, Otwombe K, Dietrich J, et al
    Does peer-navigated linkage to care work? A cross-sectional study of active linkage to care within an integrated non-communicable disease-HIV testing centre for adults in Soweto, South Africa.
    PLoS One. 2020;15:e0241014.
    >> Share

  580. LOVEDAY M, Hlangu S, Furin J
    "Take the treatment and be brave": Care experiences of pregnant women with rifampicin-resistant tuberculosis.
    PLoS One. 2020;15:e0242604.
    >> Share

  581. ZAWEDDE-MUYANJA S, Musaazi J, Manabe YC, Katamba A, et al
    Estimating the effect of pretreatment loss to follow up on TB associated mortality at public health facilities in Uganda.
    PLoS One. 2020;15:e0241611.
    >> Share


  582. Correction: Tuberculosis preventive treatment should be considered for all household contacts of pulmonary tuberculosis patients in India.
    PLoS One. 2020;15:e0244914.
    >> Share

  583. NONGHANPHITHAK D, Kaewprasert O, Chaiyachat P, Reechaipichitkul W, et al
    Whole-genome sequence analysis and comparisons between drug-resistance mutations and minimum inhibitory concentrations of Mycobacterium tuberculosis isolates causing M/XDR-TB.
    PLoS One. 2020;15:e0244829.
    >> Share

  584. PARK JW, Curtis JR, Lee H, Lee JK, et al
    Risk-benefit analysis of isoniazid monotherapy to prevent tuberculosis in patients with rheumatic diseases exposed to prolonged, high-dose glucocorticoids.
    PLoS One. 2020;15:e0244239.
    >> Share

  585. KASOZI S, Kirirabwa NS, Kimuli D, Luwaga H, et al
    Addressing the drug-resistant tuberculosis challenge through implementing a mixed model of care in Uganda.
    PLoS One. 2020;15:e0244451.
    >> Share

  586. DIAN S, Hermawan R, van Laarhoven A, Immaculata S, et al
    Brain MRI findings in relation to clinical characteristics and outcome of tuberculous meningitis.
    PLoS One. 2020;15:e0241974.
    >> Share

  587. ANANTHAKRISHNAN R, Thiagesan R, Auguesteen S, Karunakaran N, et al
    The impact of chest radiography and Xpert MTB/RIF testing among household contacts in Chennai, India.
    PLoS One. 2020;15:e0241203.
    >> Share

  588. BORNMANN L, Haunschild R, Patel VM
    Are papers addressing certain diseases perceived where these diseases are prevalent? The proposal to use Twitter data as social-spatial sensors.
    PLoS One. 2020;15:e0242550.
    >> Share

  589. DE MEDEIROS VLS, Santos FCF, Montenegro LML, Silva MDC, et al
    TST conversions and systemic interferon-gamma increase after methotrexate introduction in psoriasis patients.
    PLoS One. 2020;15:e0242098.
    >> Share

  590. KARANJA M, Kingwara L, Owiti P, Kirui E, et al
    Outcomes of isoniazid preventive therapy among people living with HIV in Kenya: A retrospective study of routine health care data.
    PLoS One. 2020;15:e0234588.
    >> Share

  591. SOMNUKE P, Ramlee R, Ratanapaiboon W, Thommaaksorn P, et al
    Factors influencing preoperative chest radiography request for elective endoscopic procedures among medical personnel.
    PLoS One. 2020;15:e0242140.
    >> Share

  592. KAY AW, Thivalapill N, Skinner D, Dube GS, et al
    Predictors of suboptimal adherence to isoniazid preventive therapy among adolescents and children living with HIV.
    PLoS One. 2020;15:e0243713.
    >> Share

  593. ISLAM MS, Chughtai AA, Nazneen A, Chowdhury KIA, et al
    A tuberculin skin test survey among healthcare workers in two public tertiary care hospitals in Bangladesh.
    PLoS One. 2020;15:e0243951.
    >> Share

  594. GOOVAERTS O, Massinga-Loembe M, Ondoa P, Ceulemans A, et al
    Lack of elevated pre-ART elastase-ANCA levels in patients developing TB-IRIS.
    PLoS One. 2020;15:e0244800.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016